{ "labelLang" : "hun", "responseDate" : "2024-03-29 11:23", "content" : { "otype" : "JournalArticle", "mtid" : 31995478, "status" : "VALIDATED", "published" : true, "comment" : "Division of Cardiology, Medical University of Graz, Graz, Austria \n Cardiac Aging & Redox Signaling Laboratory, Molecular and Cellular Pathology, Department of Pathology, Birmingham, AL, United States \n Division of Cardiovascular Medicine, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States \n Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, United States \n Fraternal Order of Eagles Diabetes Research Center, Division of Endocrinology and Metabolism, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, United States \n Cited By :37 \n Export Date: 13 April 2023 \n CODEN: FRBME \n Correspondence Address: Bugger, H.; Medical University of Graz Division of Cardiology, Auenbruggerplatz 15, Austria; email: heiko.bugger@medunigraz.at", "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2023-09-29T13:43:08.423+0000", "lastModified" : "2022-08-10T07:52:03.469+0000", "created" : "2021-05-02T07:39:46.283+0000", "creator" : { "otype" : "Admin", "mtid" : 10062334, "link" : "/api/admin/10062334", "label" : "Gáspár Renáta (SZTE admin5 (SZTE ÁOK Biokémiai Intézet))", "familyName" : "Gáspár", "givenName" : "Renáta", "published" : true, "oldId" : 10062334, "snippet" : true }, "lastDuplumSearch" : "2023-05-08T13:33:02.521+0000", "validated" : "2022-08-10T07:52:04.278+0000", "validator" : { "otype" : "Admin", "mtid" : 10015544, "link" : "/api/admin/10015544", "label" : "Csajbók Edit (SE_KK_Admin5_CSE, admin)", "familyName" : "Csajbók", "givenName" : "Edit", "published" : true, "oldId" : 10015544, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000059, "link" : "/api/subtype/10000059", "label" : "Szakcikk (Folyóiratcikk)", "name" : "Szakcikk", "nameEng" : "Article", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 101, "published" : true, "oldId" : 10000059, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Byrne, Nikole J.", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 96160255, "link" : "/api/authorship/96160255", "label" : "Byrne, Nikole J.", "listPosition" : 1, "share" : 0.25, "first" : true, "last" : false, "corresponding" : false, "familyName" : "Byrne", "givenName" : "Nikole J.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 96160256, "link" : "/api/authorship/96160256", "label" : "Rajasekaran, Namakkal S.", "listPosition" : 2, "share" : 0.25, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Rajasekaran", "givenName" : "Namakkal S.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 96160257, "link" : "/api/authorship/96160257", "label" : "Abel, E Dale", "listPosition" : 3, "share" : 0.25, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Abel", "givenName" : "E Dale", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 96160258, "link" : "/api/authorship/96160258", "label" : "Bugger, Heiko", "listPosition" : 4, "share" : 0.25, "first" : false, "last" : true, "corresponding" : false, "familyName" : "Bugger", "givenName" : "Heiko", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 18734704, "link" : "/api/publicationidentifier/18734704", "label" : "DOI: 10.1016/j.freeradbiomed.2021.03.046", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/j.freeradbiomed.2021.03.046", "realUrl" : "https://doi.org/10.1016/j.freeradbiomed.2021.03.046", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 19039552, "link" : "/api/publicationidentifier/19039552", "label" : "WoS: 000653018600005", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000653018600005", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/000653018600005", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 19039803, "link" : "/api/publicationidentifier/19039803", "label" : "Scopus: 85106553249", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85106553249", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85106553249", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 19039553, "link" : "/api/publicationidentifier/19039553", "label" : "PubMed: 33910093", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "33910093", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=33910093&dopt=Abstract", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 18734705, "link" : "/api/publicationidentifier/18734705", "label" : "Egyéb URL: https://linkinghub.elsevier.com/retrieve/pii/S0891584921002240", "source" : { "otype" : "PlainSource", "mtid" : 40, "link" : "/api/publicationsource/40", "label" : "Egyéb URL", "type" : { "otype" : "PublicationSourceType", "mtid" : 10006, "link" : "/api/publicationsourcetype/10006", "label" : "Link", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "Egyéb URL", "nameEng" : "Other URL", "linkPattern" : "@@@", "publiclyVisible" : true, "published" : true, "oldId" : 40, "snippet" : true }, "idValue" : "https://linkinghub.elsevier.com/retrieve/pii/S0891584921002240", "realUrl" : "https://linkinghub.elsevier.com/retrieve/pii/S0891584921002240", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 1638, "link" : "/api/journal/1638", "label" : "FREE RADICAL BIOLOGY AND MEDICINE 0891-5849 1873-4596", "pIssn" : "0891-5849", "eIssn" : "1873-4596", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 1638, "snippet" : true }, "volume" : "169", "firstPage" : "317", "lastPage" : "342", "firstPageOrInternalIdForSort" : "317", "pageLength" : 26, "publishedYear" : 2021, "digital" : null, "printed" : true, "sourceYear" : 2021, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-09-29", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 12, "citedCount" : 12, "ratings" : [ { "otype" : "SjrRating", "mtid" : 11196144, "link" : "/api/sjrrating/11196144", "label" : "sjr:Q1 (2021) Scopus - Biochemistry FREE RADICAL BIOLOGY AND MEDICINE 0891-5849 1873-4596", "listPos" : 64, "rankValue" : 0.24, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 1303, "link" : "/api/classificationexternal/1303", "label" : "Scopus - Biochemistry", "published" : true, "oldId" : 1303, "snippet" : true }, "ranking" : "Q1", "calculation" : "DIRECT", "published" : true, "snippet" : true } ], "ratingsForSort" : "Q1", "references" : [ { "otype" : "Reference", "mtid" : 20191477, "link" : "/api/reference/20191477", "label" : "1. Saeedi 2019: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition, Diabetes Res. Clin. Pract., DOI: 10.1016/j.diabres.2019.107843", "listPosition" : 1, "doi" : "10.1016/j.diabres.2019.107843", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191478, "link" : "/api/reference/20191478", "label" : "2. Kristensen 2017: Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report from the I-preserve trial (irbesartan in heart failure with preserved ejection, Circulation, DOI: 10.1161/CIRCULATIONAHA.116.024593", "listPosition" : 2, "doi" : "10.1161/CIRCULATIONAHA.116.024593", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191479, "link" : "/api/reference/20191479", "label" : "3. Bertoni 2004: Heart failure prevalence, incidence, and mortality in the elderly with diabetes, Diabetes Care, DOI: 10.2337/diacare.27.3.699", "listPosition" : 3, "doi" : "10.2337/diacare.27.3.699", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191480, "link" : "/api/reference/20191480", "label" : "4. Kannel 1974: Role of diabetes in congestive heart failure: the Framingham study, Am. J. Cardiol., DOI: 10.1016/0002-9149(74)90089-7", "listPosition" : 4, "doi" : "10.1016/0002-9149(74)90089-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191481, "link" : "/api/reference/20191481", "label" : "5. Gustafsson 2004: Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure, J. Am. Coll. Cardiol., DOI: 10.1016/j.jacc.2003.11.024", "listPosition" : 5, "doi" : "10.1016/j.jacc.2003.11.024", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191482, "link" : "/api/reference/20191482", "label" : "6. Lombardi 2016: Novel insight into the dangerous connection between diabetes and heart failure, Herz, DOI: 10.1007/s00059-016-4415-7", "listPosition" : 6, "doi" : "10.1007/s00059-016-4415-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191483, "link" : "/api/reference/20191483", "label" : "7. Dei Cas 2015: Concomitant diabetes mellitus and heart failure, Curr. Probl. Cardiol., DOI: 10.1016/j.cpcardiol.2014.09.002", "listPosition" : 7, "doi" : "10.1016/j.cpcardiol.2014.09.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191484, "link" : "/api/reference/20191484", "label" : "8. Maack 2018: Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-The-Art review from the translational research committee of the heart failure association-European society of cardiology, Eur. Heart J., DOI: 10.1093/eurheartj/ehy596", "listPosition" : 8, "doi" : "10.1093/eurheartj/ehy596", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191485, "link" : "/api/reference/20191485", "label" : "9. Rubler 1972: New type of cardiomyopathy associated with diabetic glomerulosclerosis, Am. J. Cardiol., DOI: 10.1016/0002-9149(72)90595-4", "listPosition" : 9, "doi" : "10.1016/0002-9149(72)90595-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191486, "link" : "/api/reference/20191486", "label" : "10. Seferović 2015: Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes, Eur. Heart J., DOI: 10.1093/eurheartj/ehv134", "listPosition" : 10, "doi" : "10.1093/eurheartj/ehv134", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191487, "link" : "/api/reference/20191487", "label" : "11. Ritchie 2020: Basic mechanisms of diabetic heart disease, Circ. Res., DOI: 10.1161/CIRCRESAHA.120.315913", "listPosition" : 11, "doi" : "10.1161/CIRCRESAHA.120.315913", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191488, "link" : "/api/reference/20191488", "label" : "12. Levelt 2016: Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes, Diabetes", "listPosition" : 12, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191489, "link" : "/api/reference/20191489", "label" : "13. Devereux 2000: Impact of diabetes on cardiac structure and function: the Strong Heart Study, Circulation, DOI: 10.1161/01.CIR.101.19.2271", "listPosition" : 13, "doi" : "10.1161/01.CIR.101.19.2271", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191490, "link" : "/api/reference/20191490", "label" : "14. Boyer 2004: Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus, Am. J. Cardiol., DOI: 10.1016/j.amjcard.2003.12.026", "listPosition" : 14, "doi" : "10.1016/j.amjcard.2003.12.026", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191491, "link" : "/api/reference/20191491", "label" : "15. Lourenço 2018: An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology, Eur. J. Heart Fail., DOI: 10.1002/ejhf.1059", "listPosition" : 15, "doi" : "10.1002/ejhf.1059", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191492, "link" : "/api/reference/20191492", "label" : "16. Barter 2003: Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis, Arterioscler. Thromb. Vasc. Biol., DOI: 10.1161/01.ATV.0000054658.91146.64", "listPosition" : 16, "doi" : "10.1161/01.ATV.0000054658.91146.64", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191493, "link" : "/api/reference/20191493", "label" : "17. Nielsen 2002: Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice, J. Biol. Chem., DOI: 10.1074/jbc.M203458200", "listPosition" : 17, "doi" : "10.1074/jbc.M203458200", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191494, "link" : "/api/reference/20191494", "label" : "18. Kajstura 2001: IGF-1 0verexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress, Diabetes, DOI: 10.2337/diabetes.50.6.1414", "listPosition" : 18, "doi" : "10.2337/diabetes.50.6.1414", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191495, "link" : "/api/reference/20191495", "label" : "19. van Linthout 2008: Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy, Basic Res. Cardiol.", "listPosition" : 19, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191496, "link" : "/api/reference/20191496", "label" : "20. Qin 2012: The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice, Circulation, DOI: 10.1161/CIRCULATIONAHA.111.067801", "listPosition" : 20, "doi" : "10.1161/CIRCULATIONAHA.111.067801", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191497, "link" : "/api/reference/20191497", "label" : "21. Shao 2019: Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats, Cardiovasc. Diabetol., DOI: 10.1186/s12933-019-0964-4", "listPosition" : 21, "doi" : "10.1186/s12933-019-0964-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191498, "link" : "/api/reference/20191498", "label" : "22. Christoffersen 2003: Cardiac lipid accumulation associated with diastolic dysfunction in obese mice, Endocrinology, DOI: 10.1210/en.2003-0242", "listPosition" : 22, "doi" : "10.1210/en.2003-0242", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191499, "link" : "/api/reference/20191499", "label" : "23. Bugger 2009: Rodent models of diabetic cardiomyopathy, DMM Disease Models and Mechanisms, DOI: 10.1242/dmm.001941", "listPosition" : 23, "doi" : "10.1242/dmm.001941", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191500, "link" : "/api/reference/20191500", "label" : "24. Dabkowski 2009: Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00467.2008", "listPosition" : 24, "doi" : "10.1152/ajpheart.00467.2008", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191501, "link" : "/api/reference/20191501", "label" : "25. Ceylan-Isik 2006: J. High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus, J. Appl. Physiol., DOI: 10.1152/japplphysiol.00988.2005", "listPosition" : 25, "doi" : "10.1152/japplphysiol.00988.2005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191502, "link" : "/api/reference/20191502", "label" : "26. De Blasio 2020: Defining the progression of diabetic cardiomyopathy in a mouse model of type 1 diabetes, Front. Physiol., 11, p. 124, DOI: 10.3389/fphys.2020.00124", "listPosition" : 26, "doi" : "10.3389/fphys.2020.00124", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191503, "link" : "/api/reference/20191503", "label" : "27. Huynh 2012: Coenzyme Q 10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes, Diabetologia, DOI: 10.1007/s00125-012-2495-3", "listPosition" : 27, "doi" : "10.1007/s00125-012-2495-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191504, "link" : "/api/reference/20191504", "label" : "28. De Blasio 2015: Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2015.04.028", "listPosition" : 28, "doi" : "10.1016/j.freeradbiomed.2015.04.028", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191505, "link" : "/api/reference/20191505", "label" : "29. Ye 2004: Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes, Diabetes, DOI: 10.2337/diabetes.53.5.1336", "listPosition" : 29, "doi" : "10.2337/diabetes.53.5.1336", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191506, "link" : "/api/reference/20191506", "label" : "30. Huynh 2013: Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2013.02.021", "listPosition" : 30, "doi" : "10.1016/j.freeradbiomed.2013.02.021", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191507, "link" : "/api/reference/20191507", "label" : "31. Shen 2006: Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy, Diabetes, DOI: 10.2337/diabetes.55.03.06.db05-1039", "listPosition" : 31, "doi" : "10.2337/diabetes.55.03.06.db05-1039", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191508, "link" : "/api/reference/20191508", "label" : "32. Valavanidis 2009: 8-Hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis, J. Environ. Sci. Health Part C Environ. Carcinog. Ecotoxicol. Rev., DOI: 10.1080/10590500902885684", "listPosition" : 32, "doi" : "10.1080/10590500902885684", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191509, "link" : "/api/reference/20191509", "label" : "33. DayanandC 2012", "listPosition" : 33, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191510, "link" : "/api/reference/20191510", "label" : "34. Delanty 1997: 8-epi PGF(2α) generation during coronary reperfusion: a potential quantitative marker of oxidant stress in vivo, Circulation, DOI: 10.1161/01.CIR.95.11.2492", "listPosition" : 34, "doi" : "10.1161/01.CIR.95.11.2492", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191511, "link" : "/api/reference/20191511", "label" : "35. Ghosh 2004: Increased efflux of glutathione conjugate in acutely diabetic cardiomyocytes, Can. J. Physiol. Pharmacol., DOI: 10.1139/y04-060", "listPosition" : 35, "doi" : "10.1139/y04-060", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191512, "link" : "/api/reference/20191512", "label" : "36. Kanazawa 2002: Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart, Am. J. Physiol. Endocrinol. Metab., DOI: 10.1152/ajpendo.00255.2001", "listPosition" : 36, "doi" : "10.1152/ajpendo.00255.2001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191513, "link" : "/api/reference/20191513", "label" : "37. Singh 2008: Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis, Diabetes, DOI: 10.2337/db08-0805", "listPosition" : 37, "doi" : "10.2337/db08-0805", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191514, "link" : "/api/reference/20191514", "label" : "38. Tocchetti 2015: Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes, Clin. Sci., DOI: 10.1042/CS20150204", "listPosition" : 38, "doi" : "10.1042/CS20150204", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191515, "link" : "/api/reference/20191515", "label" : "39. Kakkar 1995: Lipid peroxidation and activity of antioxidant enzymes in diabetic rats, Mol. Cell. Biochem., DOI: 10.1007/BF01322333", "listPosition" : 39, "doi" : "10.1007/BF01322333", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191516, "link" : "/api/reference/20191516", "label" : "40. Da Silva 2015: Attenuation of Ca2+ homeostasis, oxidative stress, and mitochondrial dysfunctions in diabetic rat heart: insulin therapy or aerobic exercise?, J. Appl. Physiol., DOI: 10.1152/japplphysiol.00915.2014", "listPosition" : 40, "doi" : "10.1152/japplphysiol.00915.2014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191517, "link" : "/api/reference/20191517", "label" : "41. Hamblin 2007: Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2006.12.018", "listPosition" : 41, "doi" : "10.1016/j.yjmcc.2006.12.018", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191518, "link" : "/api/reference/20191518", "label" : "42. Lashin 2006: Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2005.10.040", "listPosition" : 42, "doi" : "10.1016/j.freeradbiomed.2005.10.040", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191519, "link" : "/api/reference/20191519", "label" : "43. Wohaieb 1987: Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment, Diabetes, DOI: 10.2337/diab.36.2.169", "listPosition" : 43, "doi" : "10.2337/diab.36.2.169", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191520, "link" : "/api/reference/20191520", "label" : "44. Herlein 2009: Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats, Endocrinology, DOI: 10.1210/en.2008-0404", "listPosition" : 44, "doi" : "10.1210/en.2008-0404", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191521, "link" : "/api/reference/20191521", "label" : "45. Das 2012: Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis, Toxicol. Appl. Pharmacol., DOI: 10.1016/j.taap.2011.11.009", "listPosition" : 45, "doi" : "10.1016/j.taap.2011.11.009", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191522, "link" : "/api/reference/20191522", "label" : "46. Genet 2002: Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonella foenum graecum), Mol. Cell. Biochem., DOI: 10.1023/A:1016103131408", "listPosition" : 46, "doi" : "10.1023/A:1016103131408", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191523, "link" : "/api/reference/20191523", "label" : "47. Turko 2003: Protein tyrosine nitration in the mitochondria from diabetic mouse heart: implications to dysfunctional mitochondria in diabetes, J. Biol. Chem., DOI: 10.1074/jbc.M303734200", "listPosition" : 47, "doi" : "10.1074/jbc.M303734200", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191524, "link" : "/api/reference/20191524", "label" : "48. Shen 2004: Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes, Am. J. Physiol. Endocrinol. Metab., DOI: 10.1152/ajpendo.00047.2004", "listPosition" : 48, "doi" : "10.1152/ajpendo.00047.2004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191525, "link" : "/api/reference/20191525", "label" : "49. Wohaieb 1987: Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat, Can. J. Physiol. Pharmacol., 65, p. 2191, DOI: 10.1139/y87-346", "listPosition" : 49, "doi" : "10.1139/y87-346", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191526, "link" : "/api/reference/20191526", "label" : "50. Liang 2002: Overexpression of metallothionein reduces diabetic cardiomyopathy, Diabetes, DOI: 10.2337/diabetes.51.1.174", "listPosition" : 50, "doi" : "10.2337/diabetes.51.1.174", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191527, "link" : "/api/reference/20191527", "label" : "51. Parinandi 1990: Diabetic heart and kidney exhibit increased resistance to lipid peroxidation, Biochim. Biophys. Acta Lipids Lipid. Metabol., DOI: 10.1016/0005-2760(90)90261-U", "listPosition" : 51, "doi" : "10.1016/0005-2760(90)90261-U", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191528, "link" : "/api/reference/20191528", "label" : "52. Bugger 2008: Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3, Diabetes, DOI: 10.2337/db08-0079", "listPosition" : 52, "doi" : "10.2337/db08-0079", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191529, "link" : "/api/reference/20191529", "label" : "53. Bugger 2009: Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice, Diabetes, DOI: 10.2337/db09-0259", "listPosition" : 53, "doi" : "10.2337/db09-0259", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191530, "link" : "/api/reference/20191530", "label" : "54. Buchanan 2005: Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity, Endocrinology, DOI: 10.1210/en.2005-0938", "listPosition" : 54, "doi" : "10.1210/en.2005-0938", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191531, "link" : "/api/reference/20191531", "label" : "55. Corsetti 2000: Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats, Atherosclerosis, DOI: 10.1016/S0021-9150(99)00265-8", "listPosition" : 55, "doi" : "10.1016/S0021-9150(99)00265-8", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191532, "link" : "/api/reference/20191532", "label" : "56. Mariappan 2010: NF-κB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes, Cardiovasc. Res., DOI: 10.1093/cvr/cvp305", "listPosition" : 56, "doi" : "10.1093/cvr/cvp305", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191533, "link" : "/api/reference/20191533", "label" : "57. Boudina 2007: Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, Diabetes, DOI: 10.2337/db07-0481", "listPosition" : 57, "doi" : "10.2337/db07-0481", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191534, "link" : "/api/reference/20191534", "label" : "58. Das 2014: Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice : potential role of attenuated oxidative stress and altered contractile protein expression, J. Biol. Chem., DOI: 10.1074/jbc.M113.521062", "listPosition" : 58, "doi" : "10.1074/jbc.M113.521062", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191535, "link" : "/api/reference/20191535", "label" : "59. Pan 2020: 4-Hydroxy-2-nonenal attenuates 8-oxoguanine DNA glycosylase 1 activity, J. Cell. Biochem., DOI: 10.1002/jcb.29814", "listPosition" : 59, "doi" : "10.1002/jcb.29814", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191536, "link" : "/api/reference/20191536", "label" : "60. Raza 2012: Alterations in glutathione redox metabolism, oxidative stress, and mitochondrial function in the left ventricle of elderly zucker diabetic fatty rat heart, Int. J. Mol. Sci., DOI: 10.3390/ijms131216241", "listPosition" : 60, "doi" : "10.3390/ijms131216241", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191537, "link" : "/api/reference/20191537", "label" : "61. Vincent 2001: Mechanism for obesity-induced increase in myocardial lipid peroxidation, Int. J. Obes., DOI: 10.1038/sj.ijo.0801536", "listPosition" : 61, "doi" : "10.1038/sj.ijo.0801536", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191538, "link" : "/api/reference/20191538", "label" : "62. Banerjee 2020: Altered composition of high-lipid diet may generate reactive oxygen species by disturbing the balance of antioxidant and free radicals, J. Basic Clin. Physiol. Pharmacol., DOI: 10.1515/jbcpp-2019-0141", "listPosition" : 62, "doi" : "10.1515/jbcpp-2019-0141", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191539, "link" : "/api/reference/20191539", "label" : "63. Szűcs 2019: Prediabetes induced by fructose-enriched diet influences cardiac lipidome and proteome and leads to deterioration of cardiac function prior to the development of excessive oxidative stress and cell damage, Oxid. Med. Cell. Longev., DOI: 10.1155/2019/3218275", "listPosition" : 63, "doi" : "10.1155/2019/3218275", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191540, "link" : "/api/reference/20191540", "label" : "64. Koncsos 2016: Diastolic dysfunction in prediabetic male rats: role of mitochondrial oxidative stress, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00049.2016", "listPosition" : 64, "doi" : "10.1152/ajpheart.00049.2016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191541, "link" : "/api/reference/20191541", "label" : "65. Heinonen 2020: Cellular, mitochondrial and molecular alterations associate with early left ventricular diastolic dysfunction in a porcine model of diabetic metabolic derangement, Sci. Rep., DOI: 10.1038/s41598-020-68637-4", "listPosition" : 65, "doi" : "10.1038/s41598-020-68637-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191542, "link" : "/api/reference/20191542", "label" : "66. El-Omar 2004: Cardiac dysfunction in the Goto-Kakizaki rat - a model of type II diabetes mellitus, Basic Res. Cardiol., DOI: 10.1007/s00395-004-0440-4", "listPosition" : 66, "doi" : "10.1007/s00395-004-0440-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191543, "link" : "/api/reference/20191543", "label" : "67. Kuwabara 2017: Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: are they reliable models to study Type 2 Diabetes mellitus?, PloS One, DOI: 10.1371/journal.pone.0189622", "listPosition" : 67, "doi" : "10.1371/journal.pone.0189622", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191544, "link" : "/api/reference/20191544", "label" : "68. Santos 2003: Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat, Mol. Cell. Biochem., DOI: 10.1023/A:1023475022025", "listPosition" : 68, "doi" : "10.1023/A:1023475022025", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191545, "link" : "/api/reference/20191545", "label" : "69. Lai 2020: Bioenergetic functions in subpopulations of heart mitochondria are preserved in a non-obese type 2 diabetes rat model (Goto-Kakizaki), Sci. Rep.", "listPosition" : 69, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191546, "link" : "/api/reference/20191546", "label" : "70. Cook 2007: A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women’s antioxidant cardiovascular study, Arch. Intern. Med., DOI: 10.1001/archinte.167.15.1610", "listPosition" : 70, "doi" : "10.1001/archinte.167.15.1610", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191547, "link" : "/api/reference/20191547", "label" : "71. Sesso 2008: Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized controlled trial, JAMA, J. Am. Med. Assoc., DOI: 10.1001/jama.2008.600", "listPosition" : 71, "doi" : "10.1001/jama.2008.600", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191548, "link" : "/api/reference/20191548", "label" : "72. Schwingshackl 2017: Dietary Supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials, Advances in Nutrition, DOI: 10.3945/an.116.013516", "listPosition" : 72, "doi" : "10.3945/an.116.013516", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191549, "link" : "/api/reference/20191549", "label" : "73. Miller 2005: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality, Ann. Intern. Med.", "listPosition" : 73, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191550, "link" : "/api/reference/20191550", "label" : "74. Anderson 2009: Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart, J. Am. Coll. Cardiol., DOI: 10.1016/j.jacc.2009.07.031", "listPosition" : 74, "doi" : "10.1016/j.jacc.2009.07.031", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191551, "link" : "/api/reference/20191551", "label" : "75. Anderson 2011: Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00932.2010", "listPosition" : 75, "doi" : "10.1152/ajpheart.00932.2010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191552, "link" : "/api/reference/20191552", "label" : "76. Katunga 2015: Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy, Mol. Metab.", "listPosition" : 76, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191553, "link" : "/api/reference/20191553", "label" : "77. Montaigne 2014: Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients, Circulation, DOI: 10.1161/CIRCULATIONAHA.113.008476", "listPosition" : 77, "doi" : "10.1161/CIRCULATIONAHA.113.008476", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191554, "link" : "/api/reference/20191554", "label" : "78. Jaishy 2015: Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity, J. Lipid Res., DOI: 10.1194/jlr.M055152", "listPosition" : 78, "doi" : "10.1194/jlr.M055152", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191555, "link" : "/api/reference/20191555", "label" : "79. Boudina 2007: Diabetic cardiomyopathy revisited, Circulation, DOI: 10.1161/CIRCULATIONAHA.106.679597", "listPosition" : 79, "doi" : "10.1161/CIRCULATIONAHA.106.679597", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191556, "link" : "/api/reference/20191556", "label" : "80. Bugger 2008: Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome, Clin. Sci., DOI: 10.1042/CS20070166", "listPosition" : 80, "doi" : "10.1042/CS20070166", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191557, "link" : "/api/reference/20191557", "label" : "81. Turrens 2003: Mitochondrial formation of reactive oxygen species, J. Physiol., DOI: 10.1113/jphysiol.2003.049478", "listPosition" : 81, "doi" : "10.1113/jphysiol.2003.049478", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191558, "link" : "/api/reference/20191558", "label" : "82. Nishikawa 2000: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, DOI: 10.1038/35008121", "listPosition" : 82, "doi" : "10.1038/35008121", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191559, "link" : "/api/reference/20191559", "label" : "83. Pham 2014: Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart, Am. J. Physiol. Cell Physiol., DOI: 10.1152/ajpcell.00006.2014", "listPosition" : 83, "doi" : "10.1152/ajpcell.00006.2014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191560, "link" : "/api/reference/20191560", "label" : "84. Baseler 2011: Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction, Am. J. Physiol. Regul. Integr. Comp. Physiol., DOI: 10.1152/ajpregu.00423.2010", "listPosition" : 84, "doi" : "10.1152/ajpregu.00423.2010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191561, "link" : "/api/reference/20191561", "label" : "85. Bugger 2012: Genetic loss of insulin receptors worsens cardiac efficiency in diabetes, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2012.02.001", "listPosition" : 85, "doi" : "10.1016/j.yjmcc.2012.02.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191562, "link" : "/api/reference/20191562", "label" : "86. Bugger 2020: Mitochondrial ROS in myocardial ischemia reperfusion and remodeling, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis., DOI: 10.1016/j.bbadis.2020.165768", "listPosition" : 86, "doi" : "10.1016/j.bbadis.2020.165768", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191563, "link" : "/api/reference/20191563", "label" : "87. Niemann 2011: Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria, J. Am. Coll. Cardiol., DOI: 10.1016/j.jacc.2010.09.040", "listPosition" : 87, "doi" : "10.1016/j.jacc.2010.09.040", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191564, "link" : "/api/reference/20191564", "label" : "88. Sivitz 2010: Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities, Antioxidants Redox Signal., DOI: 10.1089/ars.2009.2531", "listPosition" : 88, "doi" : "10.1089/ars.2009.2531", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191565, "link" : "/api/reference/20191565", "label" : "89. Tsushima 2018: Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission, Circ. Res., DOI: 10.1161/CIRCRESAHA.117.311307", "listPosition" : 89, "doi" : "10.1161/CIRCRESAHA.117.311307", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191566, "link" : "/api/reference/20191566", "label" : "90. Orsini 2004: The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential, J. Biol. Chem., DOI: 10.1074/jbc.M401844200", "listPosition" : 90, "doi" : "10.1074/jbc.M401844200", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191567, "link" : "/api/reference/20191567", "label" : "91. Giorgio 2005: Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis, Cell, DOI: 10.1016/j.cell.2005.05.011", "listPosition" : 91, "doi" : "10.1016/j.cell.2005.05.011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191568, "link" : "/api/reference/20191568", "label" : "92. Galimov 2010: The role of p66shc in oxidative stress and apoptosis, Acta Naturae, DOI: 10.32607/20758251-2010-2-4-44-51", "listPosition" : 92, "doi" : "10.32607/20758251-2010-2-4-44-51", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191569, "link" : "/api/reference/20191569", "label" : "93. Camici 2007: Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress, Proc. Natl. Acad. Sci. U.S.A., DOI: 10.1073/pnas.0609656104", "listPosition" : 93, "doi" : "10.1073/pnas.0609656104", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191570, "link" : "/api/reference/20191570", "label" : "94. Napoli 2003: Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet, Proc. Natl. Acad. Sci. U.S.A., DOI: 10.1073/pnas.0336359100", "listPosition" : 94, "doi" : "10.1073/pnas.0336359100", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191571, "link" : "/api/reference/20191571", "label" : "95. Costantino 2018: Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66 Shc, Int. J. Cardiol., DOI: 10.1016/j.ijcard.2018.04.082", "listPosition" : 95, "doi" : "10.1016/j.ijcard.2018.04.082", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191572, "link" : "/api/reference/20191572", "label" : "96. Rota 2006: Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene, Circ. Res., DOI: 10.1161/01.RES.0000231289.63468.08", "listPosition" : 96, "doi" : "10.1161/01.RES.0000231289.63468.08", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191573, "link" : "/api/reference/20191573", "label" : "97. Kaludercic 2014: Monoamine oxidases as sources of oxidants in the heart, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2013.12.032", "listPosition" : 97, "doi" : "10.1016/j.yjmcc.2013.12.032", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191574, "link" : "/api/reference/20191574", "label" : "98. Deshwal 2017: Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease, Curr. Opin. Pharmacol., DOI: 10.1016/j.coph.2017.04.003", "listPosition" : 98, "doi" : "10.1016/j.coph.2017.04.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191575, "link" : "/api/reference/20191575", "label" : "99. Kaludercic 2011: Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury, Biochim. Biophys. Acta Mol. Cell Res., DOI: 10.1016/j.bbamcr.2010.09.010", "listPosition" : 99, "doi" : "10.1016/j.bbamcr.2010.09.010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191576, "link" : "/api/reference/20191576", "label" : "100. Umbarkar 2015: Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy, Free Radic. Biol. Med., 87, p. 263, DOI: 10.1016/j.freeradbiomed.2015.06.025", "listPosition" : 100, "doi" : "10.1016/j.freeradbiomed.2015.06.025", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191577, "link" : "/api/reference/20191577", "label" : "101. Deshwal 2018: Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes, Cell Death Differ., DOI: 10.1038/s41418-018-0071-1", "listPosition" : 101, "doi" : "10.1038/s41418-018-0071-1", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191578, "link" : "/api/reference/20191578", "label" : "102. Eisenhofer 2001: The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines, Pharmacol. Therapeut., DOI: 10.1016/S0163-7258(01)00144-9", "listPosition" : 102, "doi" : "10.1016/S0163-7258(01)00144-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191579, "link" : "/api/reference/20191579", "label" : "103. Manni 2016: Monoamine oxidase is overactivated in left and right ventricles from ischemic hearts: an intriguing therapeutic target, Oxid. Med. Cell. Longev., DOI: 10.1155/2016/4375418", "listPosition" : 103, "doi" : "10.1155/2016/4375418", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191580, "link" : "/api/reference/20191580", "label" : "104. Duicu 2016: Assessment of mitochondrial dysfunction and monoamine oxidase contribution to oxidative stress in human diabetic hearts, Oxid. Med. Cell. Longev., DOI: 10.1155/2016/8470394", "listPosition" : 104, "doi" : "10.1155/2016/8470394", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191581, "link" : "/api/reference/20191581", "label" : "105. Goll 2003: The calpain system, Physiol. Rev., DOI: 10.1152/physrev.00029.2002", "listPosition" : 105, "doi" : "10.1152/physrev.00029.2002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191582, "link" : "/api/reference/20191582", "label" : "106. Li 2009: Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes, Cardiovasc. Res., DOI: 10.1093/cvr/cvp189", "listPosition" : 106, "doi" : "10.1093/cvr/cvp189", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191583, "link" : "/api/reference/20191583", "label" : "107. Li 2011: Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes, Diabetes, DOI: 10.2337/db10-1333", "listPosition" : 107, "doi" : "10.2337/db10-1333", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191584, "link" : "/api/reference/20191584", "label" : "108. Li 2016: Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress, Biochim. Biophys. Acta - Mol. Basis Dis., DOI: 10.1016/j.bbadis.2016.08.005", "listPosition" : 108, "doi" : "10.1016/j.bbadis.2016.08.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191585, "link" : "/api/reference/20191585", "label" : "109. Ni 2016: Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type 1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy, Diabetes, 65, p. 255", "listPosition" : 109, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191586, "link" : "/api/reference/20191586", "label" : "110. Zheng 2020: Targeted inhibition of calpain in mitochondria alleviates oxidative stress-induced myocardial injury, Acta Pharmacol. Sin., DOI: 10.1038/s41401-020-00526-y", "listPosition" : 110, "doi" : "10.1038/s41401-020-00526-y", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191587, "link" : "/api/reference/20191587", "label" : "111. Lassègue 2012: Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system, Circ. Res., DOI: 10.1161/CIRCRESAHA.111.243972", "listPosition" : 111, "doi" : "10.1161/CIRCRESAHA.111.243972", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191588, "link" : "/api/reference/20191588", "label" : "112. Brandes 2010: NADPH oxidases in cardiovascular disease, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2010.04.030", "listPosition" : 112, "doi" : "10.1016/j.freeradbiomed.2010.04.030", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191589, "link" : "/api/reference/20191589", "label" : "113. Wold 2006: Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2005.12.009", "listPosition" : 113, "doi" : "10.1016/j.freeradbiomed.2005.12.009", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191590, "link" : "/api/reference/20191590", "label" : "114. Li 2006: Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch, Diabetologia, DOI: 10.1007/s00125-006-0229-0", "listPosition" : 114, "doi" : "10.1007/s00125-006-0229-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191591, "link" : "/api/reference/20191591", "label" : "115. Tsai 2012: NADPH oxidase-derived superoxide Anion-induced apoptosis is mediated via the JNK-dependent activation of NF-κB in cardiomyocytes exposed to high glucose, J. Cell. Physiol., DOI: 10.1002/jcp.22847", "listPosition" : 115, "doi" : "10.1002/jcp.22847", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191592, "link" : "/api/reference/20191592", "label" : "116. Privratsky 2003: AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase, Hypertension, DOI: 10.1161/01.HYP.0000082814.62655.85", "listPosition" : 116, "doi" : "10.1161/01.HYP.0000082814.62655.85", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191593, "link" : "/api/reference/20191593", "label" : "117. Kuo 2013: Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation, Int. J. Cardiol., DOI: 10.1016/j.ijcard.2012.09.080", "listPosition" : 117, "doi" : "10.1016/j.ijcard.2012.09.080", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191594, "link" : "/api/reference/20191594", "label" : "118. Balteau 2011: NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1, Cardiovasc. Res., DOI: 10.1093/cvr/cvr230", "listPosition" : 118, "doi" : "10.1093/cvr/cvr230", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191595, "link" : "/api/reference/20191595", "label" : "119. Balteau 2014: AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00210.2014", "listPosition" : 119, "doi" : "10.1152/ajpheart.00210.2014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191596, "link" : "/api/reference/20191596", "label" : "120. Joseph 2014: The detrimental effects of acute hyperglycemia on myocardial glucose uptake, Life Sci., DOI: 10.1016/j.lfs.2014.04.009", "listPosition" : 120, "doi" : "10.1016/j.lfs.2014.04.009", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191597, "link" : "/api/reference/20191597", "label" : "121. Shen 2009: Rac1 is required for cardiomyocyte apoptosis during hyperglycemia, Diabetes, DOI: 10.2337/db08-0617", "listPosition" : 121, "doi" : "10.2337/db08-0617", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191598, "link" : "/api/reference/20191598", "label" : "122. Roe 2011: Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction, Diabetes Obes. Metabol., DOI: 10.1111/j.1463-1326.2011.01369.x", "listPosition" : 122, "doi" : "10.1111/j.1463-1326.2011.01369.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191599, "link" : "/api/reference/20191599", "label" : "123. Joseph 2016: Inhibition of napdh oxidase 2 (nox2) prevents oxidative stress and mitochondrial abnormalities caused by saturated fat in cardiomyocytes, PloS One, DOI: 10.1371/journal.pone.0145750", "listPosition" : 123, "doi" : "10.1371/journal.pone.0145750", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191600, "link" : "/api/reference/20191600", "label" : "124. Li 2010: Deficiency of Rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes, Diabetes, DOI: 10.2337/db09-1800", "listPosition" : 124, "doi" : "10.2337/db09-1800", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191601, "link" : "/api/reference/20191601", "label" : "125. Maalouf 2012: Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes, Am. J. Physiol. Cell Physiol., DOI: 10.1152/ajpcell.00331.2011", "listPosition" : 125, "doi" : "10.1152/ajpcell.00331.2011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191602, "link" : "/api/reference/20191602", "label" : "126. Guo 2014: Effect of exenatide on the cardiac expression of adiponectin receptor 1 and NADPH oxidase subunits and heart function in streptozotocin-induced diabetic rats, Diabetol. Metab. Syndrome, DOI: 10.1186/1758-5996-6-29", "listPosition" : 126, "doi" : "10.1186/1758-5996-6-29", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191603, "link" : "/api/reference/20191603", "label" : "127. Fukuda 2010: Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db mice, J. Pharmacol. Exp. Therapeut., DOI: 10.1124/jpet.110.170373", "listPosition" : 127, "doi" : "10.1124/jpet.110.170373", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191604, "link" : "/api/reference/20191604", "label" : "128. Yang 2020: Xanthine oxidase inhibitor allopurinol improves atrial electrical remodeling in diabetic rats by inhibiting CaMKII/NCX signaling, Life Sci., 259, p. 118290, DOI: 10.1016/j.lfs.2020.118290", "listPosition" : 128, "doi" : "10.1016/j.lfs.2020.118290", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191605, "link" : "/api/reference/20191605", "label" : "129. Fan 2018: HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury, Biochem. Biophys. Res. Commun., DOI: 10.1016/j.bbrc.2018.04.090", "listPosition" : 129, "doi" : "10.1016/j.bbrc.2018.04.090", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191606, "link" : "/api/reference/20191606", "label" : "130. Rajesh 2009: Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy, J. Cell Mol. Med., DOI: 10.1111/j.1582-4934.2008.00564.x", "listPosition" : 130, "doi" : "10.1111/j.1582-4934.2008.00564.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191607, "link" : "/api/reference/20191607", "label" : "131. Gao 2012: Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes, Diabetes. Metab. Res. Rev., DOI: 10.1002/dmrr.2295", "listPosition" : 131, "doi" : "10.1002/dmrr.2295", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191608, "link" : "/api/reference/20191608", "label" : "132. Luo 2020: Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats, J. Cell Mol. Med., 24, p. 1760, DOI: 10.1111/jcmm.14870", "listPosition" : 132, "doi" : "10.1111/jcmm.14870", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191609, "link" : "/api/reference/20191609", "label" : "133. Desco 2002: Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol, Diabetes, DOI: 10.2337/diabetes.51.4.1118", "listPosition" : 133, "doi" : "10.2337/diabetes.51.4.1118", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191610, "link" : "/api/reference/20191610", "label" : "134. Pacher 2006: Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol, Pharmacol. Rev., DOI: 10.1124/pr.58.1.6", "listPosition" : 134, "doi" : "10.1124/pr.58.1.6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191611, "link" : "/api/reference/20191611", "label" : "135. D'Oria 2020: The role of oxidative stress in cardiac disease: from physiological response to injury factor, Oxidative Medicine and Cellular Longevity, DOI: 10.1155/2020/5732956", "listPosition" : 135, "doi" : "10.1155/2020/5732956", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191612, "link" : "/api/reference/20191612", "label" : "136. Mayer 1997: Biosynthesis and action of nitric oxide in mammalian cells, Trends Biochem. Sci., DOI: 10.1016/S0968-0004(97)01147-X", "listPosition" : 136, "doi" : "10.1016/S0968-0004(97)01147-X", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191613, "link" : "/api/reference/20191613", "label" : "137. Stuehr 2001: Oxygen reduction by nitric-oxide synthases, J. Biol. Chem., DOI: 10.1074/jbc.R100011200", "listPosition" : 137, "doi" : "10.1074/jbc.R100011200", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191614, "link" : "/api/reference/20191614", "label" : "138. Magenta 2014: Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction, BioMed Res. Int., DOI: 10.1155/2014/193095", "listPosition" : 138, "doi" : "10.1155/2014/193095", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191615, "link" : "/api/reference/20191615", "label" : "139. Ceriello 2002: New findings as a marker of postprandial oxidative stress", "listPosition" : 139, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191616, "link" : "/api/reference/20191616", "label" : "140. Sartoretto 2011: Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis, Proc. Natl. Acad. Sci. U.S.A., DOI: 10.1073/pnas.1111331108", "listPosition" : 140, "doi" : "10.1073/pnas.1111331108", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191617, "link" : "/api/reference/20191617", "label" : "141. Pechánová 2015: Cardiac NO signalling in the metabolic syndrome, Br. J. Pharmacol., DOI: 10.1111/bph.12960", "listPosition" : 141, "doi" : "10.1111/bph.12960", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191618, "link" : "/api/reference/20191618", "label" : "142. Simon 2014: Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2014.03.004", "listPosition" : 142, "doi" : "10.1016/j.yjmcc.2014.03.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191619, "link" : "/api/reference/20191619", "label" : "143. Amour 2007: Altered contractile response due to increased β3- adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide, Anesthesiology, DOI: 10.1097/01.anes.0000278909.40408.24", "listPosition" : 143, "doi" : "10.1097/01.anes.0000278909.40408.24", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191620, "link" : "/api/reference/20191620", "label" : "144. Jo 2011: Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice, Clin. Exp. Pharmacol. Physiol., DOI: 10.1111/j.1440-1681.2011.05535.x", "listPosition" : 144, "doi" : "10.1111/j.1440-1681.2011.05535.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191621, "link" : "/api/reference/20191621", "label" : "145. Sun 2020: Induction of caveolin-3/eNOS complex by nitroxyl (HNO) ameliorates diabetic cardiomyopathy, Redox Biol, DOI: 10.1016/j.redox.2020.101493", "listPosition" : 145, "doi" : "10.1016/j.redox.2020.101493", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191622, "link" : "/api/reference/20191622", "label" : "146. de Zeeuw 2015: Metabolic adaptations in diabetic endothelial cells, Circ. J., DOI: 10.1253/circj.CJ-15-0230", "listPosition" : 146, "doi" : "10.1253/circj.CJ-15-0230", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191623, "link" : "/api/reference/20191623", "label" : "147. Wan 2016: Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy, Cardiovasc. Res., DOI: 10.1093/cvr/cvw159", "listPosition" : 147, "doi" : "10.1093/cvr/cvw159", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191624, "link" : "/api/reference/20191624", "label" : "148. N D 2011: Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction, Diabetes Obes. Metabol., 13, p. 465, DOI: 10.1111/j.1463-1326.2011.01369.x", "listPosition" : 148, "doi" : "10.1111/j.1463-1326.2011.01369.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191625, "link" : "/api/reference/20191625", "label" : "149. Jay 2006: Oxidative stress and diabetic cardiovascular complications, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2005.06.018", "listPosition" : 149, "doi" : "10.1016/j.freeradbiomed.2005.06.018", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191626, "link" : "/api/reference/20191626", "label" : "150. Brownlee 2005: The pathobiology of diabetic complications: a unifying mechanism, Diabetes, DOI: 10.2337/diabetes.54.6.1615", "listPosition" : 150, "doi" : "10.2337/diabetes.54.6.1615", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191627, "link" : "/api/reference/20191627", "label" : "151. Ceriello 2005: Acute hyperglycaemia: a ‘new’ risk factor during myocardial infarction, Eur. Heart J., DOI: 10.1093/eurheartj/ehi049", "listPosition" : 151, "doi" : "10.1093/eurheartj/ehi049", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191628, "link" : "/api/reference/20191628", "label" : "152. Yu 2019: RNA-Seq analysis and functional characterization revealed lncRNA NONRATT007560.2 regulated cardiomyocytes oxidative stress and apoptosis induced by high glucose, J. Cell. Biochem., DOI: 10.1002/jcb.29134", "listPosition" : 152, "doi" : "10.1002/jcb.29134", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191629, "link" : "/api/reference/20191629", "label" : "153. Zhi 2004: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications, Endocr. Rev.", "listPosition" : 153, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191630, "link" : "/api/reference/20191630", "label" : "154. Abel 2012: Insulin resistance: metabolic mechanisms and consequences in the heart, Arterioscler. Thromb. Vasc. Biol., DOI: 10.1161/ATVBAHA.111.241984", "listPosition" : 154, "doi" : "10.1161/ATVBAHA.111.241984", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191631, "link" : "/api/reference/20191631", "label" : "155. Patti 2010: The role of mitochondria in the pathogenesis of type 2 diabetes, Endocr. Rev., DOI: 10.1210/er.2009-0027", "listPosition" : 155, "doi" : "10.1210/er.2009-0027", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191632, "link" : "/api/reference/20191632", "label" : "156. Lopaschuk 2010: Myocardial fatty acid metabolism in health and disease, Physiol. Rev., DOI: 10.1152/physrev.00015.2009", "listPosition" : 156, "doi" : "10.1152/physrev.00015.2009", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191633, "link" : "/api/reference/20191633", "label" : "157. Kessler 1998: Metabolism of fatty acids and glucose, Circulation, DOI: 10.1161/circ.98.13.1350/a", "listPosition" : 157, "doi" : "10.1161/circ.98.13.1350/a", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191634, "link" : "/api/reference/20191634", "label" : "158. Van De Weijer 2011: Lipotoxicity in type 2 diabetic cardiomyopathy, Cardiovasc. Res., DOI: 10.1093/cvr/cvr212", "listPosition" : 158, "doi" : "10.1093/cvr/cvr212", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191635, "link" : "/api/reference/20191635", "label" : "159. Summers 2006: Ceramides in insulin resistance and lipotoxicity, Prog. Lipid Res., DOI: 10.1016/j.plipres.2005.11.002", "listPosition" : 159, "doi" : "10.1016/j.plipres.2005.11.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191636, "link" : "/api/reference/20191636", "label" : "160. Quintela 2012: Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2012.05.045", "listPosition" : 160, "doi" : "10.1016/j.freeradbiomed.2012.05.045", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191637, "link" : "/api/reference/20191637", "label" : "161. Mazumder 2004: Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts, Diabetes, DOI: 10.2337/diabetes.53.9.2366", "listPosition" : 161, "doi" : "10.2337/diabetes.53.9.2366", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191638, "link" : "/api/reference/20191638", "label" : "162. Boudina 2007: Mitochondrial energetics in the heart in obesity-related diabetes, Diabetes, 56, p. 2457, DOI: 10.2337/db07-0481", "listPosition" : 162, "doi" : "10.2337/db07-0481", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191639, "link" : "/api/reference/20191639", "label" : "163. Carroll 2005: Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts, Am. J. Physiol. Endocrinol. Metab., DOI: 10.1152/ajpendo.00491.2004", "listPosition" : 163, "doi" : "10.1152/ajpendo.00491.2004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191640, "link" : "/api/reference/20191640", "label" : "164. Hafstad 2006: Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.01063.2005", "listPosition" : 164, "doi" : "10.1152/ajpheart.01063.2005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191641, "link" : "/api/reference/20191641", "label" : "165. Wright 2009: Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding, Cardiovasc. Res., DOI: 10.1093/cvr/cvp017", "listPosition" : 165, "doi" : "10.1093/cvr/cvp017", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191642, "link" : "/api/reference/20191642", "label" : "166. Cook 2010: Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction, Eur. Heart J., DOI: 10.1093/eurheartj/ehp396", "listPosition" : 166, "doi" : "10.1093/eurheartj/ehp396", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191643, "link" : "/api/reference/20191643", "label" : "167. Broderick 2001: Effects of chronic food restriction and exercise training on the recovery of cardiac function following ischemia, Journals Gerontol. - Ser. A Biol. Sci. Med. Sci., DOI: 10.1093/gerona/56.1.B33", "listPosition" : 167, "doi" : "10.1093/gerona/56.1.B33", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191644, "link" : "/api/reference/20191644", "label" : "168. Boudina 2009: Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart, Circulation, DOI: 10.1161/CIRCULATIONAHA.108.792101", "listPosition" : 168, "doi" : "10.1161/CIRCULATIONAHA.108.792101", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191645, "link" : "/api/reference/20191645", "label" : "169. Ritchie 2007: The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2007.03.900", "listPosition" : 169, "doi" : "10.1016/j.yjmcc.2007.03.900", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191646, "link" : "/api/reference/20191646", "label" : "170. Reaven 2012: Insulin resistance and coronary heart disease in nondiabetic individuals, Arterioscler. Thromb. Vasc. Biol., DOI: 10.1161/ATVBAHA.111.241885", "listPosition" : 170, "doi" : "10.1161/ATVBAHA.111.241885", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191647, "link" : "/api/reference/20191647", "label" : "171. Mohammed Yusof 2017: Cardioprotective effects of roselle (Hibiscus sabdariffa linn.) polyphenol-rich extract in streptozotocin-induced diabetic rats, Int. J. Cardiol., DOI: 10.1016/j.ijcard.2017.09.037", "listPosition" : 171, "doi" : "10.1016/j.ijcard.2017.09.037", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191648, "link" : "/api/reference/20191648", "label" : "172. Shimizu 2016: Physiological and pathological cardiac hypertrophy, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2016.06.001", "listPosition" : 172, "doi" : "10.1016/j.yjmcc.2016.06.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191649, "link" : "/api/reference/20191649", "label" : "173. Balderas-Villalobos 2013: Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00211.2013", "listPosition" : 173, "doi" : "10.1152/ajpheart.00211.2013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191650, "link" : "/api/reference/20191650", "label" : "174. Kaneto 2010: Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis, Mediat. Inflamm., DOI: 10.1155/2010/453892", "listPosition" : 174, "doi" : "10.1155/2010/453892", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191651, "link" : "/api/reference/20191651", "label" : "175. Mahmoud 2017: Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function, Redox Biol, DOI: 10.1016/j.redox.2017.06.001", "listPosition" : 175, "doi" : "10.1016/j.redox.2017.06.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191652, "link" : "/api/reference/20191652", "label" : "176. Palace 1999: Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions, J. Mol. Cell. Cardiol., DOI: 10.1006/jmcc.1998.0859", "listPosition" : 176, "doi" : "10.1006/jmcc.1998.0859", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191653, "link" : "/api/reference/20191653", "label" : "177. Doroshow 1980: Enzymatic defenses of the mouse heart against reactive oxygen metabolites. Alterations produced by doxorubicin, J. Clin. Invest., DOI: 10.1172/JCI109642", "listPosition" : 177, "doi" : "10.1172/JCI109642", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191654, "link" : "/api/reference/20191654", "label" : "178. Dieterich 2000: Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart, Circulation, DOI: 10.1161/01.CIR.101.1.33", "listPosition" : 178, "doi" : "10.1161/01.CIR.101.1.33", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191655, "link" : "/api/reference/20191655", "label" : "179. Di Filippo 2004: M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart, Eur. J. Pharmacol., DOI: 10.1016/j.ejphar.2004.06.037", "listPosition" : 179, "doi" : "10.1016/j.ejphar.2004.06.037", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191656, "link" : "/api/reference/20191656", "label" : "180. Turko 2003: Quantitative protein profiling in heart mitochondria from diabetic rats, J. Biol. Chem.", "listPosition" : 180, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191657, "link" : "/api/reference/20191657", "label" : "181. Arkat 2016: Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in Diabetic cardiomyopathy, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2016.06.019", "listPosition" : 181, "doi" : "10.1016/j.freeradbiomed.2016.06.019", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191658, "link" : "/api/reference/20191658", "label" : "182. Cong 2015: Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-κB signaling activation in the heart, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2015.10.010", "listPosition" : 182, "doi" : "10.1016/j.yjmcc.2015.10.010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191659, "link" : "/api/reference/20191659", "label" : "183. Turdi 2007: Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2, Life Sci., 81, p. 895, DOI: 10.1016/j.lfs.2007.07.029", "listPosition" : 183, "doi" : "10.1016/j.lfs.2007.07.029", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191660, "link" : "/api/reference/20191660", "label" : "184. Bhatt 2015: Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00378.2014", "listPosition" : 184, "doi" : "10.1152/ajpheart.00378.2014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191661, "link" : "/api/reference/20191661", "label" : "185. Baseler 2013: Reversal of mitochondrial proteomic loss in type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase, Am. J. Physiol. Regul. Integr. Comp. Physiol., DOI: 10.1152/ajpregu.00249.2012", "listPosition" : 185, "doi" : "10.1152/ajpregu.00249.2012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191662, "link" : "/api/reference/20191662", "label" : "186. Matsushima 2006: Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00427.2006", "listPosition" : 186, "doi" : "10.1152/ajpheart.00427.2006", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191663, "link" : "/api/reference/20191663", "label" : "187. McClung 2004: Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase, Proc. Natl. Acad. Sci. U.S.A., DOI: 10.1073/pnas.0308096101", "listPosition" : 187, "doi" : "10.1073/pnas.0308096101", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191664, "link" : "/api/reference/20191664", "label" : "188. Rhee 2007: Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance, Kidney Int., DOI: 10.1038/sj.ki.5002380", "listPosition" : 188, "doi" : "10.1038/sj.ki.5002380", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191665, "link" : "/api/reference/20191665", "label" : "189. Shi 2017: Sulfiredoxin involved in the protection of peroxiredoxins against hyperoxidation in the early hyperglycaemia, Exp. Cell Res., DOI: 10.1016/j.yexcr.2017.02.015", "listPosition" : 189, "doi" : "10.1016/j.yexcr.2017.02.015", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191666, "link" : "/api/reference/20191666", "label" : "190. Li 2017: Thioredoxin 2 offers protection against mitochondrial oxidative stress in H9c2 cells and against myocardial hypertrophy induced by hyperglycemia, Int. J. Mol. Sci.", "listPosition" : 190, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191667, "link" : "/api/reference/20191667", "label" : "191. Cox 2010: Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling, Biochem. J., DOI: 10.1042/BJ20091541", "listPosition" : 191, "doi" : "10.1042/BJ20091541", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191668, "link" : "/api/reference/20191668", "label" : "192. Stanley 2011: Thioredoxin reductase-2 is essential for keeping low levels of H 2O 2 emission from isolated heart mitochondria, J. Biol. Chem., DOI: 10.1074/jbc.M111.284612", "listPosition" : 192, "doi" : "10.1074/jbc.M111.284612", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191669, "link" : "/api/reference/20191669", "label" : "193. Connelly 2014: Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies, Acta Diabetol., DOI: 10.1007/s00592-014-0608-9", "listPosition" : 193, "doi" : "10.1007/s00592-014-0608-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191670, "link" : "/api/reference/20191670", "label" : "194. Myers 2016: Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00051.2016", "listPosition" : 194, "doi" : "10.1152/ajpheart.00051.2016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191671, "link" : "/api/reference/20191671", "label" : "195. Li 2003: Regulation of glutathione in cardiac myocytes, J. Mol. Cell. Cardiol.", "listPosition" : 195, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191672, "link" : "/api/reference/20191672", "label" : "196. Ghosh 2005: Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00038.2005", "listPosition" : 196, "doi" : "10.1152/ajpheart.00038.2005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191673, "link" : "/api/reference/20191673", "label" : "197. Qi 2016: Cardiac damage and dysfunction in diabetic cardiomyopathy are ameliorated by Grx1, Genet. Mol. Res., DOI: 10.4238/gmr.15039000", "listPosition" : 197, "doi" : "10.4238/gmr.15039000", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191674, "link" : "/api/reference/20191674", "label" : "198. Ceriello 2002: Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat, Diabetes, DOI: 10.2337/diabetes.51.4.1076", "listPosition" : 198, "doi" : "10.2337/diabetes.51.4.1076", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191675, "link" : "/api/reference/20191675", "label" : "199. Liu 2015: N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition, BMC Cardiovasc. Disord., DOI: 10.1186/s12872-015-0076-3", "listPosition" : 199, "doi" : "10.1186/s12872-015-0076-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191676, "link" : "/api/reference/20191676", "label" : "200. Fiordaliso 2004: Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2004.07.008", "listPosition" : 200, "doi" : "10.1016/j.yjmcc.2004.07.008", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191677, "link" : "/api/reference/20191677", "label" : "201. Yildirim 2013: Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1, Cell Biochem. Biophys., DOI: 10.1007/s12013-013-9672-y", "listPosition" : 201, "doi" : "10.1007/s12013-013-9672-y", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191678, "link" : "/api/reference/20191678", "label" : "202. Dludla 2019: N-Acetyl cysteine ameliorates hyperglycemia-induced cardiomyocyte toxicity by improving mitochondrial energetics and enhancing endogenous Coenzyme Q9/10 levels, Toxicol. Reports, 6, p. 1240, DOI: 10.1016/j.toxrep.2019.11.004", "listPosition" : 202, "doi" : "10.1016/j.toxrep.2019.11.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191679, "link" : "/api/reference/20191679", "label" : "203. Tossios 2003: N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial, J. Thorac. Cardiovasc. Surg., DOI: 10.1016/S0022-5223(03)00968-1", "listPosition" : 203, "doi" : "10.1016/S0022-5223(03)00968-1", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191680, "link" : "/api/reference/20191680", "label" : "204. Rodrigues 2009: Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress, Heart Surg. Forum, DOI: 10.1532/HSF98.20081134", "listPosition" : 204, "doi" : "10.1532/HSF98.20081134", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191681, "link" : "/api/reference/20191681", "label" : "205. Mahmoud 2011: Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial, Acta Anaesthesiol. Scand., DOI: 10.1111/j.1399-6576.2011.02492.x", "listPosition" : 205, "doi" : "10.1111/j.1399-6576.2011.02492.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191682, "link" : "/api/reference/20191682", "label" : "206. van der Pol 2019: Treating oxidative stress in heart failure: past, present and future, Eur. J. Heart Fail., DOI: 10.1002/ejhf.1320", "listPosition" : 206, "doi" : "10.1002/ejhf.1320", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191683, "link" : "/api/reference/20191683", "label" : "207. Thornalley 1985: Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals, Biochim. Biophys. Acta (BBA)/Protein Struct. Mol.", "listPosition" : 207, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191684, "link" : "/api/reference/20191684", "label" : "208. Miura 1997: Antioxidant activity of metallothionein compared with reduced glutathione, Life Sci., DOI: 10.1016/S0024-3205(97)00156-2", "listPosition" : 208, "doi" : "10.1016/S0024-3205(97)00156-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191685, "link" : "/api/reference/20191685", "label" : "209. Cai 1999: Metallothionein in radiation exposure: its induction and protective role, Toxicology, DOI: 10.1016/S0300-483X(98)00150-4", "listPosition" : 209, "doi" : "10.1016/S0300-483X(98)00150-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191686, "link" : "/api/reference/20191686", "label" : "210. Ye 2003: Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production, Diabetes, 52, p. 777, DOI: 10.2337/diabetes.52.3.777", "listPosition" : 210, "doi" : "10.2337/diabetes.52.3.777", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191687, "link" : "/api/reference/20191687", "label" : "211. Cai 2006: Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy, J. Am. Coll. Cardiol., DOI: 10.1016/j.jacc.2006.07.022", "listPosition" : 211, "doi" : "10.1016/j.jacc.2006.07.022", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191688, "link" : "/api/reference/20191688", "label" : "212. Kang 1997: Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity, J. Clin. Invest., DOI: 10.1172/JCI119672", "listPosition" : 212, "doi" : "10.1172/JCI119672", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191689, "link" : "/api/reference/20191689", "label" : "213. Cong 2014: Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase, J. Nutr. Biochem., DOI: 10.1016/j.jnutbio.2013.12.007", "listPosition" : 213, "doi" : "10.1016/j.jnutbio.2013.12.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191690, "link" : "/api/reference/20191690", "label" : "214. Cong 2013: Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp374, Am. J. Physiol. Metab., 304, p. E826", "listPosition" : 214, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191691, "link" : "/api/reference/20191691", "label" : "215. Wang 2006: Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation, Circulation", "listPosition" : 215, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191692, "link" : "/api/reference/20191692", "label" : "216. Cai 2006: Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2006.06.007", "listPosition" : 216, "doi" : "10.1016/j.freeradbiomed.2006.06.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191693, "link" : "/api/reference/20191693", "label" : "217. Cai 2004: Metallothionein as an adaptive protein prevents diabetes and its toxicity, Nonlinearity Biol. Toxicol. Med., DOI: 10.1080/15401420490464367", "listPosition" : 217, "doi" : "10.1080/15401420490464367", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191694, "link" : "/api/reference/20191694", "label" : "218. Lu 2007: Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications, Curr. Med. Chem.", "listPosition" : 218, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191695, "link" : "/api/reference/20191695", "label" : "219. Liu 2014: Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage, Journal of Diabetes Investigation, DOI: 10.1111/jdi.12250", "listPosition" : 219, "doi" : "10.1111/jdi.12250", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191696, "link" : "/api/reference/20191696", "label" : "220. Sultana 2016: Garlic activates SIRT-3 to prevent cardiac oxidative stress and mitochondrial dysfunction in diabetes, Life Sci., DOI: 10.1016/j.lfs.2016.08.030", "listPosition" : 220, "doi" : "10.1016/j.lfs.2016.08.030", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191697, "link" : "/api/reference/20191697", "label" : "221. Sun 2018: Exogenous H2S switches cardiac energy substrate metabolism by regulating SIRT3 expression in db/db mice, J. Mol. Med., DOI: 10.1007/s00109-017-1616-3", "listPosition" : 221, "doi" : "10.1007/s00109-017-1616-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191698, "link" : "/api/reference/20191698", "label" : "222. Sun 2019: Exogenous H2S reduces the acetylation levels of mitochondrial respiratory enzymes via regulating the NAD+-SIRT3 pathway in cardiac tissues of db/db mice, Am. J. Physiol. Endocrinol. Metab., DOI: 10.1152/ajpendo.00326.2018", "listPosition" : 222, "doi" : "10.1152/ajpendo.00326.2018", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191699, "link" : "/api/reference/20191699", "label" : "223. Song 2020: Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation, Acta Pharmacol. Sin.", "listPosition" : 223, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191700, "link" : "/api/reference/20191700", "label" : "224. Zong 2020: SIRT3 is a downstream target of PPAR-α implicated in high glucose-induced cardiomyocyte injury in AC16 cells, Exp. Ther. Med.", "listPosition" : 224, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191701, "link" : "/api/reference/20191701", "label" : "225. Li 2020: Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury, J. Cell. Mol. Med, 25, p. 323, DOI: 10.1111/jcmm.16052", "listPosition" : 225, "doi" : "10.1111/jcmm.16052", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191702, "link" : "/api/reference/20191702", "label" : "226. Luo 2019: Blockage of ROS and MAPKs-mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathy, Toxicol. Appl. Pharmacol., DOI: 10.1016/j.taap.2019.03.005", "listPosition" : 226, "doi" : "10.1016/j.taap.2019.03.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191703, "link" : "/api/reference/20191703", "label" : "227. Motohashi 2004: Nrf2-Keap1 defines a physiologically important stress response mechanism, Trends Mol. Med., DOI: 10.1016/j.molmed.2004.09.003", "listPosition" : 227, "doi" : "10.1016/j.molmed.2004.09.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191704, "link" : "/api/reference/20191704", "label" : "228. Chen 2018: Nrf2 at the heart of oxidative stress and cardiac protection, Physiol. Genom., DOI: 10.1152/physiolgenomics.00041.2017", "listPosition" : 228, "doi" : "10.1152/physiolgenomics.00041.2017", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191705, "link" : "/api/reference/20191705", "label" : "229. Chen 2014: Diabetic cardiomyopathy and its prevention by Nrf2: current status, Diabetes and Metabolism Journal, DOI: 10.4093/dmj.2014.38.5.337", "listPosition" : 229, "doi" : "10.4093/dmj.2014.38.5.337", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191706, "link" : "/api/reference/20191706", "label" : "230. Kaspar 2009: Nrf2:INrf2 (Keap1) signaling in oxidative stress, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2009.07.035", "listPosition" : 230, "doi" : "10.1016/j.freeradbiomed.2009.07.035", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191707, "link" : "/api/reference/20191707", "label" : "231. Qiang Ma 2013: Disruption of Nrf2 synergizes with high glucose to cause heightened myocardial oxidative stress and severe cardiomyopathy in diabetic mice, J. Diabetes Metabol., DOI: 10.4172/2155-6156.S7-002", "listPosition" : 231, "doi" : "10.4172/2155-6156.S7-002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191708, "link" : "/api/reference/20191708", "label" : "232. Liu, H. et al. Spiraeoside protects human cardiomyocytes against high glucose-induced injury, oxidative stress, and apoptosis by activation of PI3K/Akt/Nrf2 pathway. J. Biochem. Mol. Toxicol. n/a, e22548.", "listPosition" : 232, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191709, "link" : "/api/reference/20191709", "label" : "233. Tan 2011: Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo, Diabetes, DOI: 10.2337/db10-1164", "listPosition" : 233, "doi" : "10.2337/db10-1164", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191710, "link" : "/api/reference/20191710", "label" : "234. Li 2020: Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus, Theranostics, 10, p. 2675, DOI: 10.7150/thno.40735", "listPosition" : 234, "doi" : "10.7150/thno.40735", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191711, "link" : "/api/reference/20191711", "label" : "235. Nishio 1998: Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats, Diabetes, DOI: 10.2337/diab.47.8.1318", "listPosition" : 235, "doi" : "10.2337/diab.47.8.1318", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191712, "link" : "/api/reference/20191712", "label" : "236. Bai 2013: Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation, J. Mol. Cell. Cardiol., DOI: 10.1016/j.yjmcc.2013.01.008", "listPosition" : 236, "doi" : "10.1016/j.yjmcc.2013.01.008", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191713, "link" : "/api/reference/20191713", "label" : "237. He 2009: Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes, J. Mol. Cell. Cardiol., 46, p. 47, DOI: 10.1016/j.yjmcc.2008.10.007", "listPosition" : 237, "doi" : "10.1016/j.yjmcc.2008.10.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191714, "link" : "/api/reference/20191714", "label" : "238. Thorwald 2019: Nrf2-related gene expression is impaired during a glucose challenge in type II diabetic rat hearts, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2018.10.405", "listPosition" : 238, "doi" : "10.1016/j.freeradbiomed.2018.10.405", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191715, "link" : "/api/reference/20191715", "label" : "239. Gu 2017: Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy, Diabetes, DOI: 10.2337/db15-1274", "listPosition" : 239, "doi" : "10.2337/db15-1274", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191716, "link" : "/api/reference/20191716", "label" : "240. Zhao 2013: Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy, PloS One, 8", "listPosition" : 240, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191717, "link" : "/api/reference/20191717", "label" : "241. Li 2019: Bailcalin protects against diabetic cardiomyopathy through Keap1/Nrf2/AMPK-mediated antioxidative and lipid-lowering effects, Oxid. Med. Cell. Longev.", "listPosition" : 241, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191718, "link" : "/api/reference/20191718", "label" : "242. Lian 2017: The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice, Biomed. Pharmacother., 93, p. 1175, DOI: 10.1016/j.biopha.2017.05.148", "listPosition" : 242, "doi" : "10.1016/j.biopha.2017.05.148", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191719, "link" : "/api/reference/20191719", "label" : "243. Dludla 2017: Aspalathin protects the heart against hyperglycemia-induced oxidative damage by up-regulating Nrf2 expression, Molecules, DOI: 10.3390/molecules22010129", "listPosition" : 243, "doi" : "10.3390/molecules22010129", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191720, "link" : "/api/reference/20191720", "label" : "244. Li 2019: Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy, Chem. Biol. Interact.", "listPosition" : 244, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191721, "link" : "/api/reference/20191721", "label" : "245. Ying 2018: Phloretin prevents diabetic cardiomyopathy by dissociating Keap1/Nrf2 complex and inhibiting oxidative stress, Front. Endocrinol. (Lausanne)., DOI: 10.3389/fendo.2018.00774", "listPosition" : 245, "doi" : "10.3389/fendo.2018.00774", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191722, "link" : "/api/reference/20191722", "label" : "246. Zang 2020: Autophagy inhibition enables Nrf2 to exaggerate the progression of diabetic cardiomyopathy in mice, Diabetes, DOI: 10.2337/db19-1176", "listPosition" : 246, "doi" : "10.2337/db19-1176", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191723, "link" : "/api/reference/20191723", "label" : "247. Li 2012: Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy, Exp. Diabetes Res., DOI: 10.1155/2012/216512", "listPosition" : 247, "doi" : "10.1155/2012/216512", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191724, "link" : "/api/reference/20191724", "label" : "248. Chartoumpekis 2013: New player on an old field; the Keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome, Curr. Diabetes Rev., DOI: 10.2174/1573399811309020005", "listPosition" : 248, "doi" : "10.2174/1573399811309020005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191725, "link" : "/api/reference/20191725", "label" : "249. Xu 2010: ALDH2 genetic polymorphism and the risk of type II diabetes mellitus in CAD patients, Hypertens. Res., DOI: 10.1038/hr.2009.178", "listPosition" : 249, "doi" : "10.1038/hr.2009.178", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191726, "link" : "/api/reference/20191726", "label" : "250. Cao 2019: ALDH2 overexpression alleviates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation, J. Diabetes Res., DOI: 10.1155/2019/4857921", "listPosition" : 250, "doi" : "10.1155/2019/4857921", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191727, "link" : "/api/reference/20191727", "label" : "251. Guo 2015: A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy, Biochim. Biophys. Acta - Mol. Basis Dis., DOI: 10.1016/j.bbadis.2014.05.017", "listPosition" : 251, "doi" : "10.1016/j.bbadis.2014.05.017", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191728, "link" : "/api/reference/20191728", "label" : "252. Hu 2016: Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α, Oncotarget", "listPosition" : 252, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191729, "link" : "/api/reference/20191729", "label" : "253. Cai 2001: Oxidative stress and diabetic cardiomyopathy: a brief review, Cardiovasc. Toxicol., DOI: 10.1385/CT:1:3:181", "listPosition" : 253, "doi" : "10.1385/CT:1:3:181", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191730, "link" : "/api/reference/20191730", "label" : "254. Varga 2015: Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis., DOI: 10.1016/j.bbadis.2014.06.030", "listPosition" : 254, "doi" : "10.1016/j.bbadis.2014.06.030", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191731, "link" : "/api/reference/20191731", "label" : "255. Wallace 2005: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine, Annu. Rev. Genet., DOI: 10.1146/annurev.genet.39.110304.095751", "listPosition" : 255, "doi" : "10.1146/annurev.genet.39.110304.095751", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191732, "link" : "/api/reference/20191732", "label" : "256. Sun 2020: Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice, Diabetes, DOI: 10.2337/db19-0991", "listPosition" : 256, "doi" : "10.2337/db19-0991", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191733, "link" : "/api/reference/20191733", "label" : "257. He 2012: Disruption of Nrf2 synergizes with high glucose to cause heightened myocardial oxidative stress and severe cardiomyopathy in diabetic mice, J. Diabetes Metab. Suppl, 7, p. 2", "listPosition" : 257, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191734, "link" : "/api/reference/20191734", "label" : "258. Wang 2011: Cardiac overexpression of 8-oxoguanine dna glycosylase 1 protects mitochondrial dna and reduces cardiac fibrosis following transaortic constriction, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00157.2011", "listPosition" : 258, "doi" : "10.1152/ajpheart.00157.2011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191735, "link" : "/api/reference/20191735", "label" : "259. Kaji 1985: Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of Type 2 (non-insulin-dependent) diabetic women, Klin. Wochenschr., DOI: 10.1007/BF01733829", "listPosition" : 259, "doi" : "10.1007/BF01733829", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191736, "link" : "/api/reference/20191736", "label" : "260. Griesmacher 1995: Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus, Am. J. Med., DOI: 10.1016/S0002-9343(99)80347-7", "listPosition" : 260, "doi" : "10.1016/S0002-9343(99)80347-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191737, "link" : "/api/reference/20191737", "label" : "261. Kesavulu 2001: Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease, Diabetes Res. Clin. Pract., DOI: 10.1016/S0168-8227(01)00238-8", "listPosition" : 261, "doi" : "10.1016/S0168-8227(01)00238-8", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191738, "link" : "/api/reference/20191738", "label" : "262. Turko 2001: Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.2001.281.6.H2289", "listPosition" : 262, "doi" : "10.1152/ajpheart.2001.281.6.H2289", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191739, "link" : "/api/reference/20191739", "label" : "263. Shishehbor 2003: Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy, J. Am. Med. Assoc., DOI: 10.1001/jama.289.13.1675", "listPosition" : 263, "doi" : "10.1001/jama.289.13.1675", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191740, "link" : "/api/reference/20191740", "label" : "264. Cai 2005: Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy, Diabetes, DOI: 10.2337/diabetes.54.6.1829", "listPosition" : 264, "doi" : "10.2337/diabetes.54.6.1829", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191741, "link" : "/api/reference/20191741", "label" : "265. Turko 2002: Protein nitration in cardiovascular diseases, Pharmacol. Rev., DOI: 10.1124/pr.54.4.619", "listPosition" : 265, "doi" : "10.1124/pr.54.4.619", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191742, "link" : "/api/reference/20191742", "label" : "266. Lu 2010: Oxidative and nitrative modifications of α-enolase in cardiac proteins from diabetic rats, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2010.01.010", "listPosition" : 266, "doi" : "10.1016/j.freeradbiomed.2010.01.010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191743, "link" : "/api/reference/20191743", "label" : "267. Chatham 2010: Protein O-GlcNAcylation: a critical regulator of the cellular response to stress, Curr. Signal Transduct. Ther., DOI: 10.2174/157436210790226492", "listPosition" : 267, "doi" : "10.2174/157436210790226492", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191744, "link" : "/api/reference/20191744", "label" : "268. Qin 2017: Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications, Pharmacol. Res., DOI: 10.1016/j.phrs.2016.12.016", "listPosition" : 268, "doi" : "10.1016/j.phrs.2016.12.016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191745, "link" : "/api/reference/20191745", "label" : "269. Hu 2009: Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose, J. Biol. Chem., DOI: 10.1074/jbc.M808518200", "listPosition" : 269, "doi" : "10.1074/jbc.M808518200", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191746, "link" : "/api/reference/20191746", "label" : "270. Makino 2011: Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes, Am. J. Physiol. Regul. Integr. Comp. Physiol., DOI: 10.1152/ajpregu.00437.2010", "listPosition" : 270, "doi" : "10.1152/ajpregu.00437.2010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191747, "link" : "/api/reference/20191747", "label" : "271. Gawlowski 2012: Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes, J. Biol. Chem., DOI: 10.1074/jbc.M112.390682", "listPosition" : 271, "doi" : "10.1074/jbc.M112.390682", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191748, "link" : "/api/reference/20191748", "label" : "272. Banerjee 2015: Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria, Proc. Natl. Acad. Sci. U.S.A., DOI: 10.1073/pnas.1424017112", "listPosition" : 272, "doi" : "10.1073/pnas.1424017112", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191749, "link" : "/api/reference/20191749", "label" : "273. Erickson 2013: Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation, Nature, DOI: 10.1038/nature12537", "listPosition" : 273, "doi" : "10.1038/nature12537", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191750, "link" : "/api/reference/20191750", "label" : "274. Bias 2009: Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification, J. Biol. Chem.", "listPosition" : 274, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191751, "link" : "/api/reference/20191751", "label" : "275. Goldin 2006: Advanced glycation end products: sparking the development of diabetic vascular injury, Circulation, DOI: 10.1161/CIRCULATIONAHA.106.621854", "listPosition" : 275, "doi" : "10.1161/CIRCULATIONAHA.106.621854", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191752, "link" : "/api/reference/20191752", "label" : "276. Wang 2006: Causes and characteristics of diabetic cardiomyopathy, Rev. Diabet. Stud., DOI: 10.1900/RDS.2006.3.108", "listPosition" : 276, "doi" : "10.1900/RDS.2006.3.108", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191753, "link" : "/api/reference/20191753", "label" : "277. Aragno 2006: Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes, Endocrinology, DOI: 10.1210/en.2006-0728", "listPosition" : 277, "doi" : "10.1210/en.2006-0728", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191754, "link" : "/api/reference/20191754", "label" : "278. Willemsen 2011: Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients, Eur. J. Heart Fail., DOI: 10.1093/eurjhf/hfq168", "listPosition" : 278, "doi" : "10.1093/eurjhf/hfq168", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191755, "link" : "/api/reference/20191755", "label" : "279. Kopytek 2020: Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes, Cardiovasc. Diabetol., 19, p. 92, DOI: 10.1186/s12933-020-01068-7", "listPosition" : 279, "doi" : "10.1186/s12933-020-01068-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191756, "link" : "/api/reference/20191756", "label" : "280. Yu 2012: Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats, PloS One, DOI: 10.1371/journal.pone.0052013", "listPosition" : 280, "doi" : "10.1371/journal.pone.0052013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191757, "link" : "/api/reference/20191757", "label" : "281. Wang 2020: Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy, Acta Pharmacol. Sin., DOI: 10.1038/s41401-020-00538-8", "listPosition" : 281, "doi" : "10.1038/s41401-020-00538-8", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191758, "link" : "/api/reference/20191758", "label" : "282. Yan 2014: Effects of advanced glycation end products on calcium handling in cardiomyocytes, Cardiol., DOI: 10.1159/000364779", "listPosition" : 282, "doi" : "10.1159/000364779", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191759, "link" : "/api/reference/20191759", "label" : "283. Sayej 2016: Advanced glycation end products induce obesity and hepatosteatosis in CD-1 wild-type mice, BioMed Res. Int., DOI: 10.1155/2016/7867852", "listPosition" : 283, "doi" : "10.1155/2016/7867852", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191760, "link" : "/api/reference/20191760", "label" : "284. Anderson 1999: The myeloperoxidase system of human phagocytes generates N(ε)- (carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation, J. Clin. Invest., DOI: 10.1172/JCI3042", "listPosition" : 284, "doi" : "10.1172/JCI3042", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191761, "link" : "/api/reference/20191761", "label" : "285. Cai 2012: Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1, Proc. Natl. Acad. Sci. U.S.A., DOI: 10.1073/pnas.1205847109", "listPosition" : 285, "doi" : "10.1073/pnas.1205847109", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191762, "link" : "/api/reference/20191762", "label" : "286. Grossin 2015: Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice, Mol. Nutr. Food Res., DOI: 10.1002/mnfr.201400643", "listPosition" : 286, "doi" : "10.1002/mnfr.201400643", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191763, "link" : "/api/reference/20191763", "label" : "287. Diamant 2003: Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus, J. Am. Coll. Cardiol., DOI: 10.1016/S0735-1097(03)00625-9", "listPosition" : 287, "doi" : "10.1016/S0735-1097(03)00625-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191764, "link" : "/api/reference/20191764", "label" : "288. Scheuermann-Freestone 2003: Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes, Circulation, DOI: 10.1161/01.CIR.0000072789.89096.10", "listPosition" : 288, "doi" : "10.1161/01.CIR.0000072789.89096.10", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191765, "link" : "/api/reference/20191765", "label" : "289. Szabadkai 2008: Mitochondria: the hub of cellular Ca2+ signaling, Physiology, DOI: 10.1152/physiol.00046.2007", "listPosition" : 289, "doi" : "10.1152/physiol.00046.2007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191766, "link" : "/api/reference/20191766", "label" : "290. Kobayashi 2015: Autophagy and mitophagy in diabetic cardiomyopathy, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis., DOI: 10.1016/j.bbadis.2014.05.020", "listPosition" : 290, "doi" : "10.1016/j.bbadis.2014.05.020", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191767, "link" : "/api/reference/20191767", "label" : "291. Frustaci 2000: Myocardial cell death in human diabetes, Circ. Res., DOI: 10.1161/01.RES.87.12.1123", "listPosition" : 291, "doi" : "10.1161/01.RES.87.12.1123", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191768, "link" : "/api/reference/20191768", "label" : "292. Cai 2002: Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome c-mediated caspase-3 activation pathway, Diabetes, DOI: 10.2337/diabetes.51.6.1938", "listPosition" : 292, "doi" : "10.2337/diabetes.51.6.1938", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191769, "link" : "/api/reference/20191769", "label" : "293. Cai 2003: J. Cell death and diabetic cardiomyopathy, Cardiovasc. Toxicol., DOI: 10.1385/CT:3:3:219", "listPosition" : 293, "doi" : "10.1385/CT:3:3:219", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191770, "link" : "/api/reference/20191770", "label" : "294. Wu 2020: Curcumin protects cardiomyopathy damage through inhibiting the production of reactive oxygen species in type 2 diabetic mice, Biochem. Biophys. Res. Commun., DOI: 10.1016/j.bbrc.2020.05.053", "listPosition" : 294, "doi" : "10.1016/j.bbrc.2020.05.053", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191771, "link" : "/api/reference/20191771", "label" : "295. Li 2019: Exogenous hydrogen sulfide protects against high glucose-induced apoptosis and oxidative stress by inhibiting the STAT3/HIF-1α pathway in H9c2 cardiomyocytes, Exp. Ther. Med.", "listPosition" : 295, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191772, "link" : "/api/reference/20191772", "label" : "296. Guo 2015: Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK, Mol. Cell. Endocrinol., 412, p. 85, DOI: 10.1016/j.mce.2015.05.034", "listPosition" : 296, "doi" : "10.1016/j.mce.2015.05.034", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191773, "link" : "/api/reference/20191773", "label" : "297. Wei 2013: Palmitate induces H9c2 cell apoptosis by increasing reactive oxygen species generation and activation of the ERK1/2 signaling pathway, Mol. Med. Rep., DOI: 10.3892/mmr.2013.1276", "listPosition" : 297, "doi" : "10.3892/mmr.2013.1276", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191774, "link" : "/api/reference/20191774", "label" : "298. Oh 2014: P38α mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate, Biochem. Biophys. Res. Commun., DOI: 10.1016/j.bbrc.2014.06.023", "listPosition" : 298, "doi" : "10.1016/j.bbrc.2014.06.023", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191775, "link" : "/api/reference/20191775", "label" : "299. Andrea 2000: Myocardial cell death in human diabetes, Circ. Res., 87, p. 1123, DOI: 10.1161/01.RES.87.12.1123", "listPosition" : 299, "doi" : "10.1161/01.RES.87.12.1123", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191776, "link" : "/api/reference/20191776", "label" : "300. Munasinghe 2016: Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway, Int. J. Cardiol., DOI: 10.1016/j.ijcard.2015.08.111", "listPosition" : 300, "doi" : "10.1016/j.ijcard.2015.08.111", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191777, "link" : "/api/reference/20191777", "label" : "301. Zang 2020: Autophagy inhibition enables Nrf2 to exaggerate the progression of diabetic cardiomyopathy in mice, Diabetes, p. db191176", "listPosition" : 301, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191778, "link" : "/api/reference/20191778", "label" : "302. Flarsheim 1996: Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.1996.271.1.H192", "listPosition" : 302, "doi" : "10.1152/ajpheart.1996.271.1.H192", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191779, "link" : "/api/reference/20191779", "label" : "303. Chung 2013: MITOCHONDRIA-TARGETED antioxidant ameliorates diet-induced diabetes and diastolic dysfunction, J. Am. Coll. Cardiol., DOI: 10.1016/S0735-1097(13)60597-5", "listPosition" : 303, "doi" : "10.1016/S0735-1097(13)60597-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191780, "link" : "/api/reference/20191780", "label" : "304. Kralik 2005: Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes, Cardiovasc. Toxicol., 5, p. 285, DOI: 10.1385/CT:5:3:285", "listPosition" : 304, "doi" : "10.1385/CT:5:3:285", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191781, "link" : "/api/reference/20191781", "label" : "305. Dikalova 2010: Therapeutic targeting of mitochondrial superoxide in hypertension, Circ. Res., DOI: 10.1161/CIRCRESAHA.109.214601", "listPosition" : 305, "doi" : "10.1161/CIRCRESAHA.109.214601", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191782, "link" : "/api/reference/20191782", "label" : "306. Ni 2016: Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2015.11.013", "listPosition" : 306, "doi" : "10.1016/j.freeradbiomed.2015.11.013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191783, "link" : "/api/reference/20191783", "label" : "307. Kelso 2001: Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties, J. Biol. Chem., DOI: 10.1074/jbc.M009093200", "listPosition" : 307, "doi" : "10.1074/jbc.M009093200", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191784, "link" : "/api/reference/20191784", "label" : "308. Lim 2011: Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity, Cell. Physiol. Biochem., DOI: 10.1159/000335802", "listPosition" : 308, "doi" : "10.1159/000335802", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191785, "link" : "/api/reference/20191785", "label" : "309. Ng 2014: The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease, Free Radic. Biol. Med., DOI: 10.1016/j.freeradbiomed.2014.03.003", "listPosition" : 309, "doi" : "10.1016/j.freeradbiomed.2014.03.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191786, "link" : "/api/reference/20191786", "label" : "310. Chacko 2010: Prevention of diabetic nephropathy in Ins2+/-AkitaJ mice by the mitochondria-targeted therapy MitoQ, Biochem. J., DOI: 10.1042/BJ20100308", "listPosition" : 310, "doi" : "10.1042/BJ20100308", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191787, "link" : "/api/reference/20191787", "label" : "311. Adlam 2005: Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury, Faseb. J., DOI: 10.1096/fj.05-3718com", "listPosition" : 311, "doi" : "10.1096/fj.05-3718com", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191788, "link" : "/api/reference/20191788", "label" : "312. Rossman 2018: Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults, Hypertension, DOI: 10.1161/HYPERTENSIONAHA.117.10787", "listPosition" : 312, "doi" : "10.1161/HYPERTENSIONAHA.117.10787", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191789, "link" : "/api/reference/20191789", "label" : "313. Ahmad 2020: Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy, Pharmacol. Res., 161, p. 105112, DOI: 10.1016/j.phrs.2020.105112", "listPosition" : 313, "doi" : "10.1016/j.phrs.2020.105112", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191790, "link" : "/api/reference/20191790", "label" : "314. Zhang 2010: Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging, Am. J. Physiol. Cell Physiol., 299, p. H985, DOI: 10.1152/ajpheart.00489.2010", "listPosition" : 314, "doi" : "10.1152/ajpheart.00489.2010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191791, "link" : "/api/reference/20191791", "label" : "315. Soufi 2012: Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats, Gen. Physiol. Biophys., DOI: 10.4149/gpb_2012_039", "listPosition" : 315, "doi" : "10.4149/gpb_2012_039", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191792, "link" : "/api/reference/20191792", "label" : "316. Beaudoin 2014: Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats, J. Physiol., DOI: 10.1113/jphysiol.2013.270538", "listPosition" : 316, "doi" : "10.1113/jphysiol.2013.270538", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191793, "link" : "/api/reference/20191793", "label" : "317. Bagul 2015: Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3, J. Nutr. Biochem., 26, p. 1298, DOI: 10.1016/j.jnutbio.2015.06.006", "listPosition" : 317, "doi" : "10.1016/j.jnutbio.2015.06.006", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191794, "link" : "/api/reference/20191794", "label" : "318. Wang 2014: Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice, J. Cell Mol. Med.", "listPosition" : 318, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191795, "link" : "/api/reference/20191795", "label" : "319. Fiorani 2010: Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid, J. Nutr. Biochem., DOI: 10.1016/j.jnutbio.2009.01.014", "listPosition" : 319, "doi" : "10.1016/j.jnutbio.2009.01.014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191796, "link" : "/api/reference/20191796", "label" : "320. Castillo 2018: Quercetin prevents diastolic dysfunction induced by a high-cholesterol diet: role of oxidative stress and bioenergetics in hyperglycemic rats, Oxid. Med. Cell. Longev., DOI: 10.1155/2018/7239123", "listPosition" : 320, "doi" : "10.1155/2018/7239123", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191797, "link" : "/api/reference/20191797", "label" : "321. Sun 2014: Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis, Food Chem. Toxicol.", "listPosition" : 321, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191798, "link" : "/api/reference/20191798", "label" : "322. Packer 1994: Vitamin E is Nature’s master antioxidant, Sci. Med., 1, p. 54", "listPosition" : 322, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191799, "link" : "/api/reference/20191799", "label" : "323. Kaul 1993: Free radicals and the heart, J. Pharmacol. Toxicol. Methods, DOI: 10.1016/1056-8719(93)90008-3", "listPosition" : 323, "doi" : "10.1016/1056-8719(93)90008-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191800, "link" : "/api/reference/20191800", "label" : "324. Aydemir-Koksoy 2010: Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress, J. Nutr. Biochem., DOI: 10.1016/j.jnutbio.2009.06.006", "listPosition" : 324, "doi" : "10.1016/j.jnutbio.2009.06.006", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191801, "link" : "/api/reference/20191801", "label" : "325. Li 2012: Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid, Cardiovasc. Diabetol., DOI: 10.1186/1475-2840-11-73", "listPosition" : 325, "doi" : "10.1186/1475-2840-11-73", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191802, "link" : "/api/reference/20191802", "label" : "326. Hamblin 2007: Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-Prostaglandin F2α and oxidized glutathione, J. Card. Fail., DOI: 10.1016/j.cardfail.2007.07.002", "listPosition" : 326, "doi" : "10.1016/j.cardfail.2007.07.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191803, "link" : "/api/reference/20191803", "label" : "327. Wold 2004: Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism, Biochem. Biophys. Res. Commun., DOI: 10.1016/j.bbrc.2004.04.138", "listPosition" : 327, "doi" : "10.1016/j.bbrc.2004.04.138", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191804, "link" : "/api/reference/20191804", "label" : "328. Yusuf 2000: Vitamin E supplementation and cardiovascular events in high-risk patients, N. Engl. J. Med.", "listPosition" : 328, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191805, "link" : "/api/reference/20191805", "label" : "329. Myung 2013: Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials, BMJ, DOI: 10.1136/bmj.f10", "listPosition" : 329, "doi" : "10.1136/bmj.f10", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191806, "link" : "/api/reference/20191806", "label" : "330. Timimi 1998: Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus, J. Am. Coll. Cardiol., DOI: 10.1016/S0735-1097(97)00536-6", "listPosition" : 330, "doi" : "10.1016/S0735-1097(97)00536-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191807, "link" : "/api/reference/20191807", "label" : "331. Ting 1996: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus, J. Clin. Invest., DOI: 10.1172/JCI118394", "listPosition" : 331, "doi" : "10.1172/JCI118394", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191808, "link" : "/api/reference/20191808", "label" : "332. Beckman 2003: Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00403.2003", "listPosition" : 332, "doi" : "10.1152/ajpheart.00403.2003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191809, "link" : "/api/reference/20191809", "label" : "333. Chen 2006: High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance, Am. J. Physiol. Heart Circ. Physiol.", "listPosition" : 333, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191810, "link" : "/api/reference/20191810", "label" : "334. Economides 2005: The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients, Diabetes, DOI: 10.2337/diabetes.54.1.204", "listPosition" : 334, "doi" : "10.2337/diabetes.54.1.204", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191811, "link" : "/api/reference/20191811", "label" : "335. Lonn 2005: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial, J. Am. Med. Assoc., DOI: 10.1001/jama.294.4.426-a", "listPosition" : 335, "doi" : "10.1001/jama.294.4.426-a", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191812, "link" : "/api/reference/20191812", "label" : "336. Gutierrez 2009: The response of γ vitamin E to varying dosages of α vitamin E plus vitamin C, Metabolism, DOI: 10.1016/j.metabol.2008.11.003", "listPosition" : 336, "doi" : "10.1016/j.metabol.2008.11.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191813, "link" : "/api/reference/20191813", "label" : "337. Dakhale 2011: Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study, Adv. Pharmacol. Sci.", "listPosition" : 337, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191814, "link" : "/api/reference/20191814", "label" : "338. Mazloom 2011: Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients, Pakistan J. Biol. Sci., DOI: 10.3923/pjbs.2011.900.904", "listPosition" : 338, "doi" : "10.3923/pjbs.2011.900.904", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191815, "link" : "/api/reference/20191815", "label" : "339. Illison 2011: The relationship between plasma α-tocopherol concentration and vitamin E intake in patients with type 2 diabetes mellitus, Int. J. Vitam. Nutr. Res., DOI: 10.1024/0300-9831/a000046", "listPosition" : 339, "doi" : "10.1024/0300-9831/a000046", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191816, "link" : "/api/reference/20191816", "label" : "340. El-Aal 2018: The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: a single-blinded randomized controlled clinical trial, Diabetes Metab. Syndr. Clin. Res. Rev., DOI: 10.1016/j.dsx.2018.03.013", "listPosition" : 340, "doi" : "10.1016/j.dsx.2018.03.013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191817, "link" : "/api/reference/20191817", "label" : "341. Jackson 1998: Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations, Circ. Res., DOI: 10.1161/01.RES.83.9.916", "listPosition" : 341, "doi" : "10.1161/01.RES.83.9.916", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191818, "link" : "/api/reference/20191818", "label" : "342. Dormont 2020: Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents, Sci. Adv., DOI: 10.1126/sciadv.aaz5466", "listPosition" : 342, "doi" : "10.1126/sciadv.aaz5466", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191819, "link" : "/api/reference/20191819", "label" : "343. Gaudin 2014: Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury, Nat. Nanotechnol., DOI: 10.1038/nnano.2014.274", "listPosition" : 343, "doi" : "10.1038/nnano.2014.274", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191820, "link" : "/api/reference/20191820", "label" : "344. Kotelevets 2017: A squalene-based nanomedicine for oral treatment of colon cancer, Canc. Res., DOI: 10.1158/0008-5472.CAN-16-1741", "listPosition" : 344, "doi" : "10.1158/0008-5472.CAN-16-1741", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191821, "link" : "/api/reference/20191821", "label" : "345. Bentinger 2007: The antioxidant role of coenzyme Q, Mitochondrion, DOI: 10.1016/j.mito.2007.02.006", "listPosition" : 345, "doi" : "10.1016/j.mito.2007.02.006", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191822, "link" : "/api/reference/20191822", "label" : "346. Di Lorenzo 2020: Clinical evidence for Q10 coenzyme supplementation in heart failure: from energetics to functional improvement, J. Clin. Med., DOI: 10.3390/jcm9051266", "listPosition" : 346, "doi" : "10.3390/jcm9051266", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191823, "link" : "/api/reference/20191823", "label" : "347. Neal 2017: Canagliflozin and cardiovascular and renal events in type 2 diabetes, N. Engl. J. Med., DOI: 10.1056/NEJMoa1611925", "listPosition" : 347, "doi" : "10.1056/NEJMoa1611925", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191824, "link" : "/api/reference/20191824", "label" : "348. Zinman 2015: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes, N. Engl. J. Med., DOI: 10.1056/NEJMoa1504720", "listPosition" : 348, "doi" : "10.1056/NEJMoa1504720", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191825, "link" : "/api/reference/20191825", "label" : "349. Wiviott 2019: Dapagliflozin and cardiovascular outcomes in type 2 diabetes, N. Engl. J. Med., DOI: 10.1056/NEJMoa1812389", "listPosition" : 349, "doi" : "10.1056/NEJMoa1812389", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191826, "link" : "/api/reference/20191826", "label" : "350. Packer 2020: Cardiovascular and renal outcomes with empagliflozin in heart failure, N. Engl. J. Med., DOI: 10.1056/NEJMoa2022190", "listPosition" : 350, "doi" : "10.1056/NEJMoa2022190", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191827, "link" : "/api/reference/20191827", "label" : "351. Lee 2019: Empagliflozin attenuates myocardial sodium and calcium dysregulation and reverses cardiac remodeling in streptozotocin-induced diabetic rats, Int. J. Mol. Sci.", "listPosition" : 351, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191828, "link" : "/api/reference/20191828", "label" : "352. Kolijn 2020: Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation, Cardiovasc. Res.", "listPosition" : 352, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191829, "link" : "/api/reference/20191829", "label" : "353. Xue 2019: Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice, Clin. Sci., DOI: 10.1042/CS20190585", "listPosition" : 353, "doi" : "10.1042/CS20190585", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191830, "link" : "/api/reference/20191830", "label" : "354. Qian 2020: A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction, Biochem. Pharmacol., DOI: 10.1016/j.bcp.2020.114209", "listPosition" : 354, "doi" : "10.1016/j.bcp.2020.114209", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191831, "link" : "/api/reference/20191831", "label" : "355. Li 2019: SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart, Cardiovasc. Diabetol., DOI: 10.1186/s12933-019-0816-2", "listPosition" : 355, "doi" : "10.1186/s12933-019-0816-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191832, "link" : "/api/reference/20191832", "label" : "356. Natali 2017: Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial, Cardiovasc. Diabetol., DOI: 10.1186/s12933-017-0615-6", "listPosition" : 356, "doi" : "10.1186/s12933-017-0615-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191833, "link" : "/api/reference/20191833", "label" : "357. Pfeffer 2015: Lixisenatide in patients with type 2 diabetes and acute coronary syndrome, N. Engl. J. Med., DOI: 10.1056/NEJMoa1509225", "listPosition" : 357, "doi" : "10.1056/NEJMoa1509225", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191834, "link" : "/api/reference/20191834", "label" : "358. Holman 2017: Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes, N. Engl. J. Med., DOI: 10.1056/NEJMoa1612917", "listPosition" : 358, "doi" : "10.1056/NEJMoa1612917", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191835, "link" : "/api/reference/20191835", "label" : "359. Husain 2019: Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes, N. Engl. J. Med., DOI: 10.1056/NEJMoa1901118", "listPosition" : 359, "doi" : "10.1056/NEJMoa1901118", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191836, "link" : "/api/reference/20191836", "label" : "360. Marso 2016: Liraglutide and cardiovascular outcomes in type 2 diabetes, N. Engl. J. Med.", "listPosition" : 360, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191837, "link" : "/api/reference/20191837", "label" : "361. Marso 2016: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes, N. Engl. J. Med.", "listPosition" : 361, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191838, "link" : "/api/reference/20191838", "label" : "362. Ding 2019: Exenatide protects against cardiac dysfunction by attenuating oxidative stress in the diabetic mouse heart, Front. Endocrinol. (Lausanne)., DOI: 10.3389/fendo.2019.00202", "listPosition" : 362, "doi" : "10.3389/fendo.2019.00202", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191839, "link" : "/api/reference/20191839", "label" : "363. Zhang 2020: GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction, Chem. Biol. Interact, 332, p. 109252, DOI: 10.1016/j.cbi.2020.109252", "listPosition" : 363, "doi" : "10.1016/j.cbi.2020.109252", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191840, "link" : "/api/reference/20191840", "label" : "364. Al-Rasheed 2016: Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats, Drug Des. Dev. Ther.", "listPosition" : 364, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191841, "link" : "/api/reference/20191841", "label" : "365. Apaijai 2013: Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats, Br. J. Pharmacol., DOI: 10.1111/bph.12176", "listPosition" : 365, "doi" : "10.1111/bph.12176", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191842, "link" : "/api/reference/20191842", "label" : "366. Nath 2017: A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans, J. Pharmacol. Toxicol. Methods, DOI: 10.1016/j.vascn.2016.10.007", "listPosition" : 366, "doi" : "10.1016/j.vascn.2016.10.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191843, "link" : "/api/reference/20191843", "label" : "367. Aroor 2017: Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice, Cardiovasc. Diabetol., DOI: 10.1186/s12933-017-0544-4", "listPosition" : 367, "doi" : "10.1186/s12933-017-0544-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191844, "link" : "/api/reference/20191844", "label" : "368. Zhang 2018: Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits, Cardiovasc. Diabetol., DOI: 10.1186/s12933-018-0803-z", "listPosition" : 368, "doi" : "10.1186/s12933-018-0803-z", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191845, "link" : "/api/reference/20191845", "label" : "369. Zhou 2018: Sitagliptin protects cardiac function by reducing Nitroxidative stress and promoting autophagy in zucker diabetic fatty (ZDF) rats, Cardiovasc. Drugs Ther., DOI: 10.1007/s10557-018-6831-9", "listPosition" : 369, "doi" : "10.1007/s10557-018-6831-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191846, "link" : "/api/reference/20191846", "label" : "370. Spencer 2018: Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes, PloS One, DOI: 10.1371/journal.pone.0200249", "listPosition" : 370, "doi" : "10.1371/journal.pone.0200249", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191847, "link" : "/api/reference/20191847", "label" : "371. Aroor 2013: Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male zucker obese rats, Endocrinology, DOI: 10.1210/en.2013-1096", "listPosition" : 371, "doi" : "10.1210/en.2013-1096", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191848, "link" : "/api/reference/20191848", "label" : "372. Bostick 2014: Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity, Metabolism, DOI: 10.1016/j.metabol.2014.04.002", "listPosition" : 372, "doi" : "10.1016/j.metabol.2014.04.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191849, "link" : "/api/reference/20191849", "label" : "373. Miller 1996: Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes, Clin. Sci., DOI: 10.1042/cs0900189", "listPosition" : 373, "doi" : "10.1042/cs0900189", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191850, "link" : "/api/reference/20191850", "label" : "374. Miller 1999: Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus, J. Am. Soc. Nephrol., 10, p. 1778, DOI: 10.1681/ASN.V1081778", "listPosition" : 374, "doi" : "10.1681/ASN.V1081778", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191851, "link" : "/api/reference/20191851", "label" : "375. Thomas 2013: Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor, Clin. Sci., DOI: 10.1042/CS20120448", "listPosition" : 375, "doi" : "10.1042/CS20120448", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191852, "link" : "/api/reference/20191852", "label" : "376. Sukumaran 2017: Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1–7/Mas receptor cascade, Biochem. Pharmacol., DOI: 10.1016/j.bcp.2017.07.022", "listPosition" : 376, "doi" : "10.1016/j.bcp.2017.07.022", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191853, "link" : "/api/reference/20191853", "label" : "377. Ge 2019: Feature article: LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis, Exp. Biol. Med., DOI: 10.1177/1535370219861283", "listPosition" : 377, "doi" : "10.1177/1535370219861283", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191854, "link" : "/api/reference/20191854", "label" : "378. Manning 2008: The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals, Diabetes Res. Clin. Pract., DOI: 10.1016/j.diabres.2008.04.015", "listPosition" : 378, "doi" : "10.1016/j.diabres.2008.04.015", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191855, "link" : "/api/reference/20191855", "label" : "379. Chakraborty 2011: Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients, Diabetes Res. Clin. Pract., DOI: 10.1016/j.diabres.2010.11.030", "listPosition" : 379, "doi" : "10.1016/j.diabres.2010.11.030", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191856, "link" : "/api/reference/20191856", "label" : "380. Liakopoulos 2012: Preoperative statin therapy for patients undergoing cardiac surgery, Cochrane Database Syst. Rev., DOI: 10.1002/14651858.CD008493.pub2", "listPosition" : 380, "doi" : "10.1002/14651858.CD008493.pub2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191857, "link" : "/api/reference/20191857", "label" : "381. Williamson 1999: The role of cytosolic reductive stress in oxidant formation and diabetic complications, Diabetes Res. Clin. Pract.", "listPosition" : 381, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191858, "link" : "/api/reference/20191858", "label" : "382. Evans 2002: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr. Rev., DOI: 10.1210/er.2001-0039", "listPosition" : 382, "doi" : "10.1210/er.2001-0039", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191859, "link" : "/api/reference/20191859", "label" : "383. Teodoro 2013: The NAD ratio redox paradox: why does too much reductive power cause oxidative stress?, Toxicol. Mech. Methods, DOI: 10.3109/15376516.2012.759305", "listPosition" : 383, "doi" : "10.3109/15376516.2012.759305", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191860, "link" : "/api/reference/20191860", "label" : "384. Tilton 1992: Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+, Kidney Int., DOI: 10.1038/ki.1992.121", "listPosition" : 384, "doi" : "10.1038/ki.1992.121", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191861, "link" : "/api/reference/20191861", "label" : "385. Goodman 2020: Hepatic NADH reductive stress underlies common variation in metabolic traits, Nature, DOI: 10.1038/s41586-020-2337-2", "listPosition" : 385, "doi" : "10.1038/s41586-020-2337-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191862, "link" : "/api/reference/20191862", "label" : "386. Wu 2016: Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications", "listPosition" : 386, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191863, "link" : "/api/reference/20191863", "label" : "387. Giacco 2010: Oxidative stress and diabetic complications, Circ. Res., DOI: 10.1161/CIRCRESAHA.110.223545", "listPosition" : 387, "doi" : "10.1161/CIRCRESAHA.110.223545", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191864, "link" : "/api/reference/20191864", "label" : "388. Cotter 1992: Polyol pathway-mediated changes in cardiac muscle contractile properties: studies in streptozotocin-diabetic and galactose-fed rats, Exp. Physiol., DOI: 10.1113/expphysiol.1992.sp003649", "listPosition" : 388, "doi" : "10.1113/expphysiol.1992.sp003649", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191865, "link" : "/api/reference/20191865", "label" : "389. Williamson 1993: Hyperglycemic pseudohypoxia and diabetic complications, Diabetes, DOI: 10.2337/diab.42.6.801", "listPosition" : 389, "doi" : "10.2337/diab.42.6.801", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191866, "link" : "/api/reference/20191866", "label" : "390. Ido 1996: Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction", "listPosition" : 390, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191867, "link" : "/api/reference/20191867", "label" : "391. Steinmetz 1973: The sorbitol pathway and the complications of diabetes, N. Engl. J. Med., DOI: 10.1056/NEJM197304192881609", "listPosition" : 391, "doi" : "10.1056/NEJM197304192881609", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191868, "link" : "/api/reference/20191868", "label" : "392. Li 2008: Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts, Cardiovasc. Diabetol., DOI: 10.1186/1475-2840-7-33", "listPosition" : 392, "doi" : "10.1186/1475-2840-7-33", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191869, "link" : "/api/reference/20191869", "label" : "393. Velmurugan 2013: Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes, Cardiovasc. Res., DOI: 10.1093/cvr/cvt125", "listPosition" : 393, "doi" : "10.1093/cvr/cvt125", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191870, "link" : "/api/reference/20191870", "label" : "394. Cheng 2012: Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in hep G2 cells, J. Agric. Food Chem., DOI: 10.1021/jf302831d", "listPosition" : 394, "doi" : "10.1021/jf302831d", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191871, "link" : "/api/reference/20191871", "label" : "395. Uruno 2013: The Keap1-Nrf2 system prevents onset of diabetes mellitus, Mol. Cell Biol., DOI: 10.1128/MCB.00225-13", "listPosition" : 395, "doi" : "10.1128/MCB.00225-13", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191872, "link" : "/api/reference/20191872", "label" : "396. Kumar 2018: Activation of Nrf2 is required for normal and ChREBPA-augmented glucose-stimulated B-cell proliferation, Diabetes, DOI: 10.2337/db17-0943", "listPosition" : 396, "doi" : "10.2337/db17-0943", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191873, "link" : "/api/reference/20191873", "label" : "397. Zang 2018: Nrf2 exaggerates cardiomyopathy associated with type 1 diabetes in mice, Diabetes", "listPosition" : 397, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191874, "link" : "/api/reference/20191874", "label" : "398. Zhao 2018: Oxidative stress-induced miR-27a targets the redox gene nuclear factor erythroid 2-related factor 2 in diabetic embryopathy, Am. J. Obstet. Gynecol., DOI: 10.1016/j.ajog.2017.10.040", "listPosition" : 398, "doi" : "10.1016/j.ajog.2017.10.040", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191875, "link" : "/api/reference/20191875", "label" : "399. Yan 2014: Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress, Journal of Diabetes Research, DOI: 10.1155/2014/137919", "listPosition" : 399, "doi" : "10.1155/2014/137919", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191876, "link" : "/api/reference/20191876", "label" : "400. Conti 2004: High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., DOI: 10.1152/ajpregu.00521.2002", "listPosition" : 400, "doi" : "10.1152/ajpregu.00521.2002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191877, "link" : "/api/reference/20191877", "label" : "401. Kumar 2013: Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats, PloS One", "listPosition" : 401, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191878, "link" : "/api/reference/20191878", "label" : "402. Wu 2018: Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway, Aging Cell, DOI: 10.1111/acel.12763", "listPosition" : 402, "doi" : "10.1111/acel.12763", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 20191879, "link" : "/api/reference/20191879", "label" : "403. Monji 2013: Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes, Am. J. Physiol. Heart Circ. Physiol., DOI: 10.1152/ajpheart.00990.2012", "listPosition" : 403, "doi" : "10.1152/ajpheart.00990.2012", "published" : false, "snippet" : true } ], "hasCitationDuplums" : false, "userChangeableUntil" : "2021-07-31T07:39:59.802+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 45, "ownerInstituteCount" : 143, "directInstituteCount" : 0, "authorCount" : 4, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/31995478", "label" : "Byrne Nikole J. et al. Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. (2021) FREE RADICAL BIOLOGY AND MEDICINE 0891-5849 1873-4596 169 317-342", "template" : "